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Metals may have contrasting biological effects. Iron, a component of a variety of 
iron-containing proteins, plays an important role in maintaining a healthy human body. 
In contrast, cadmium, a contaminant and carcinogen, has been considered one of the 
most toxic elements in the environment. As a defending mechanism against the 
exposure to cadmium, cells increase expression of cytoprotective genes such as heme 
oxygenase-1 (HO-1). Although both the importance of iron and the toxicity of 
cadmium are well known, it is not clear whether iron is required for the defending 
mechanism (that is, the upregulation of HO-1) against the toxicity of cadmium. In my 
thesis project, the effects of cadmium on HO-1 in HCT116 human colon epithelial 
cells with or without iron deficiency were investigated. It was found that cadmium 
upregulated HO-1 mRNA and protein expression and enzyme activity, but these 
effects were decreased by desferoxamine (DFO), an iron chelator, suggesting iron 
plays a critical role in cadmium-induced upregulation of HO-1. This conclusion was 
supported by two other observations: 1) another iron chelator, 2’,2’-dipyridyl (DPD), 
also decreased the upregulating effects of cadmium on HO-1 mRNA and protein 
expression; 2) iron sulfate, but not zinc sulfate and copper sulfate, restored the 
upregulating effects of cadmium on HO-1 mRNA and protein expression and enzyme 
activity in iron-deficient cells caused by the pretreatments with iron chelators, DFO or 
DPD. Further experiments were conducted to help explain the observations. There 
were two primary findings: 1) cadmium decreased intracellular glutathione levels, 
similar in the effects of glutathione inhibitors, ethacrynic acid (EA) and buthionine 
sulfoximine (BSO); however, only cadmium and EA, but not BSO, increased the 
expression of HO-1 mRNA and the nuclear expression of nuclear factor-E2-related 
factor-2 (Nrf-2), suggesting that cadmium may have the same effect as EA to directly 
react with intracellular glutathione; 2) being similar in effect to iron chelators, 
NADPH oxidase (NOX) inhibitors such as apocynin and diphenyleneiodonium (DPI), 
and superoxide scavenger, tiron, decreased the upregulating effects of cadmium on 
HO-1 mRNA and protein expression and enzyme activity. Compiled together, the 
results suggest that NOX-produced ROS play an important role in cadmium-induced 
HO-1 upregulation; cadmium induces intracellular accumulation of ROS by depleting 
intracellular glutathione, and increases nuclear Nrf-2 expression, which all lead to the 
upregulation of HO-1 expression. Moreover, it is possible that iron chelators, DFO 
and DPD, deplete iron contained in heme, a component of NOX, decreasing 
NOX-produced ROS, therefore decreasing the upregulating effect of cadmium on 
HO-1. In conclusion, the results imply that cadmium could be more toxic to 
iron-deficient cells than to iron-sufficient cells, suggesting that cadmium exposure 
could result in more severe consequences in an iron-deficient population than in a 
healthy population. 
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CHAPTER I 
INTRODUCTION 
Review of literature 
1. Brief introduction of the function, induction, and transcriptional regulation of heme 
oxygenase-1 
Heme oxygenase (HO) is a rate-limiting enzyme that catalyzes the degradation 
of heme during the process of which free iron, carbon monoxide (CO), and biliverdin 
are produced. Biliverdin is then converted to bilirubin rapidly by biliverdin reductase 
(Figure I-1, page 2). To date, three isoforms of HO have been identified: HO-1, HO-2, 
and HO-3 (McCoubrey 1997). Among them, HO-2 is considered as a constitutively 
expressed isoform which is similar to HO-3; HO-1 is the inducible isoform and is also 
known as a 32-kDa heat shock protein (Keyse 1989). HO-1 could be induced by a 
variety of extra- or intra-cellular stress including the exposure to ultraviolet (UV) 
radiation, oxidative stress, hypoxia, heme, endotoxin, inflammatory cytokines, and 
heavy metals (Keyse 1989, Applegate 1991, Rizzardina 1993). The induction of HO-1 
has been believed to be a protective response, and has been reported to be a rapid 
protective mechanism in rhabdomyolysis-induced kidney injury in rat (Nath 1992) 
and to have protective effects on cardiac xenograft and cold preservation of rat liver 
graft (Soares 1998, Redaelli 2002). It also has beeen reported that HO-1 induction 
may reduce the ischemia/reperfusion injury and chronic allograft deterioration in 
kidney transplants (Tullius 2002) and may protect skin fibroblasts against UV 
light-induced oxidative stress (Vile 1993). In contrast, HO-1 deficiency may increase 
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Figure I-1. Heme degradation catalyzed by heme oxygenase. Heme is degraded 
to free iron (Fe++), carbon monoxide (CO), and biliverdin by heme oxygenase (HO). 
Biliverdin is then rapidly converted to bilirubin by biliverdin reductase. 
iron accumulation in mice and decrease stress defense against oxidant damage in cells 
(Poss 1997). It was reported that a six year old human patient with HO-1 deficiency 
exhibited growth retardation, persistent anemia, and eventually died of intracranial 
hemorrhage (Yachie 1999).  
The basic mechanism of the protective effects of HO-1 has not been fully 
demonstrated. But it has been believed that the products heme degradation, carbon 
monoxide (CO), biliverdin/bilirubin, and iron, of the degradation of heme by HO-1 
play important roles. CO, which is well known as a toxic air pollutant, has been 
shown to have a variety of biological functions related to neurotransmission (Snyder 
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1998), protection against oxidative injury and cell death (Brouard 2000), cell 
proliferation (Morita 1997), and tolerance of organ transplantation (Sato 2001). CO 
has been reported to have the properties to inhibit platelet aggregation and smooth 
muscle relaxation (Ramos 1989). CO also has been shown to have an 
anti-inflammatory effect by regulating proinflammatory cytokines including tumor 
necrosis factor α (TNF-α), interleukin (IL)-1β, and IL-6 and anti-inflammatory 
cytokine IL-10 via the p38 and c-Jun N-terminal kinase mitogen-activated protein 
kinase (MAPK) pathways (Otterbein 2000, Morse 2003).  
Another product of the degradation of heme by HO-1 is biliverdin. Biliverdin is 
quickly converted by biliverdin reductase to bilirubin, which is known as a toxin to 
the central nervous system (CNS) in newborns (Kappas 2004). Biliverdin and 
bilirubin have been shown to have diverse protective effects in vitro and in vivo. It 
has been reported that bilirubin has the property to scavenge ROS in vitro, reduce 
cellular oxidative damage, and attenuate oxidant stress in vivo (Stocker 1987). 
Furthermore, bilirubin has also been shown to have a protective effect against 
oxidative stress caused by hydrogen peroxide (Sedlak 2004). Besides that, biliverdin 
has been reported to have protective effects against lung injury, lethal endotoxemia, 
liver ischemia/reperfusion injury, and inflammatory response in a lipopolysaccharide 
(LPS)-induced shock model in rat (Sarady-Andrews 2005). In addition, studies have 
shown that the absence of human biliverdin reductase, the enzyme converts biliverdin 
to bilirubin, attenuated arsenate-induced cell injury and increased apoptosis in 293 
kidney cells (Miralem 2005). 
The functions of ferrous iron, the last product of the degradation of heme by 
HO-1, are controversial. On one hand, ferrous iron is known to have the property to 
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increase intracellular ROS by converting hydrogen peroxide to hydroxyl radical via 
Fenton reaction. On the other hand, the release of iron from heme may increase the 
synthesis of ferritin, which in turn functions as an iron scavenger (Eisenstein 1991). 
Studies have shown that ferritin may protect endothelial cells against oxidative stress 
induced by iron and UV light (Vile 1993).  
As mentioned above, HO-1 could be induced in a variety of circumstances 
including UV radiation, oxidative stress, hypoxia, heme, endotoxin, inflammatory 
cytokines, and heavy metals. This induction is regulated at a transcriptional level. 
Several transcription factors (TFs) have been identified to be involved in the induction 
of HO-1. Among them, nuclear factor (NF)-κB, activator protein-1 (AP-1), and 
nuclear factor-E2-related factor-2 (Nrf-2) have been considered to be the most 
important ones. Although a stimulus may activate more than one TFs, it is thought 
that the activation of NF-κB is relative more important in cytokine- or other 
mediator-induced inflammatory and immune response; AP-1 is related to cell growth 
or death; and Nrf-2 is activated by cellular stress caused by xenobiotics and oxidants.  
Studies have shown that the activation of HO-1 expression involves interactions 
between a variety of basic-leucine zipper (bZIP) TFs and enhancer elements including 
Maf recognition element (MARE) (Kataoka 1994) and the stress responsive element 
(StRE) (Inamdar 1996). Nrf-2 is a bZIP protein which prominently dimerizes with 
another bZIP protein, small Maf protein (Itoh 1995, Marini 1997). This dimer then 
may bind to MARE, resulting in the activation of HO-1 gene expression. However, 
the small Maf protein may also bind to basic leucine zipper transcription factor 1 
(Bach1), another bZIP protein, forming a heterodimer which may competitively bind 
to MARE, and repress HO-1 gene expression. Therefore, Bach1 is regarded as a 
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repressor of HO-1 gene expression (Igarashi 1998). In normal conditions, Nrf-2 is 
sequestered in the cytoplasm as an inactive form by Kelch-like-ECH-associated 
protein 1 (Keap1). Keap1 binds to Nrf-2, preventing Nrf-2 to be translocated into 
nucleus via increasing the degradation of Nrf-2 by ubiquitin-proteasome pathway, 
hence preventing HO-1 to be activated by Nrf-2 (Steward 2003). Keap1 is a protein 
rich in cysteine residues which make it to be sensitive to xenobiotics and oxidative 
stresses (Itoh 1999 and 2003, McMahon 2003). In the condition of oxidative stress, 
Nrf-2 is dissociated from Keap1 and is translocated into nucleus where it forms 
heterodimer with small Maf protein, and activate HO-1 gene expression (Figure I-2, 
page 6). 
Cadmium has been shown to be a strong inducer of the expression of HO-1 gene 
(Taketani 1989). As for the mechanism, it has been reported that cadmium upreguates 
HO-1 gene expression by increasing the export of Bach1 from the nucleus (Suzuki 
2003) and by stabilizing Nrf-2 through a mechanism of decreasing the degradation of 
Nrf-2 by the ubiquitin-proteasome pathway (Steward 2003). 
2. Brief introduction of the exposure, absorption, and toxicity of cadmium 
Cadmium, which has a long elimination half-life of 10-30 years, has been 
considered one of the most toxic elements in the environment (Jarup 1998). Cadmium 
has been classified as a contaminant by the U.S. Environmental Protection Agency 
(EPA) (ATSDR 1998) and a carcinogen of category 1 by the International Agency for 
Research on Cancer (IARC) (IARC 1993). It has been estimated that at least 512,000 
U.S. employees work in an environment exposing them to cadmium (Wittman 2002) 
and the situation in developing countries is believed to be much more severe (Sethi 
2006).  
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Figure I-2. The transcriptional regulation of heme oxygenase-1 gene expression. 
A: in normal conditions, the heterodimer of Bach1 and small Maf protein binds to 
MARE, and Keap1 sequesters Nrf-2 in an inactive form in cytosol, preventing Nrf-2 
to be translocated into nucleus and increasing the degradation of Nrf-2 by proteasome, 
hence preventing HO-1 gene expression activated by Nrf-2. B: with the intracellular 
accumulation of reactive oxygen species (ROS), Nrf-2 is dissociated from Keap1 and 
is then translocated into nucleus where it forms heterodimer with small Maf protein, 
and activates HO-1 gene expression. 
Cadmium exposure may result from mining, industrial emission, contaminated 
soil, pigments, plastic stabilizers, anti-corrosive products, and tobacco smoke. Plants 
absorb cadmium from cadmium-contaminated soil or water resulting in elevated 
cadmium concentrations in plant and animal products. People consuming these plant 
and animal products may have a higher risk of cadmium toxicity. Cadmium may be 
absorbed from respiratory tract and gastrointestinal tract. The absorbance from 
gastrointestinal tract is lower than from respiratory tract, but study has shown that low 
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dietary intakes of calcium, protein, zinc, iron, and copper may increase the absorption 
of cadmium. After being absorbed, cadmium is mostly accumulated in liver where it 
induces and binds to a cysteine-rich protein, metallothionein, and in kidney where it 
ultimately damages renal function (Jarup 1998).    
Due to its long half-life, the accumulation of cadmium in human body is 
irreversible, causing kidney dysfunction, bone deformation, obstructive lung disease, 
hypertension, and cancers of lung, prostate, breast, and pancreas. The mechanism of 
cadmium toxicity has not been fully understood. But oxidative stress induced by 
cadmium seems to be involved. It has been shown that cadmium has the property to 
induce the production of reactive oxygen species (ROS), causing lipid peroxidation of 
cell membrane and DNA damage. The DNA damage has been believed to be involved 
in carcinogenesis caused by cadmium. 
3. Brief introduction of the definition, production, and property of reactive oxygen 
species 
Reactive oxygen species (ROS), including superoxide, hydroxyl radicals, and 
hydrogen peroxide, are small molecules and free radicals derived from oxygen. 
Reactive oxygen species (ROS) are constantly generated in response to a variety of 
stimuli. The generation of ROS starts from the production of superoxide which is 
rapidly converted to hydrogen peroxide by superoxide dismutase or in a low pH 
environment. Hydrogen peroxide then may be converted to hydroxyl radical via 
Fenton reaction. ROS could be generated as by-products of the usage of oxygen in 
mitochondrion, xanthine oxidase, peroxisome, and cytochrome P450 (Balaban 2005, 
Harrison 2004, Schrader 2004, Gottlieb 2003). ROS may also be produced from 
NADPH oxidase (NOX) and function as defending molecules against exogenous 
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pathogens in neutrophils (Geiszt 2003). 
Studies have shown that ROS have the property to interact with a variety of 
molecules including carbohydrates, proteins, lipids, and nucleic acids, therefore 
appear to have a wide range of functions including immune defense (Geiszt 2003), 
inflammatory (Swindel 2007), cellular signaling (Furst 2005), gene expression (Clark 
2004), cell growth regulation (Burdon 1995), and angiogenesis (Kuroki 1996) (Figure 
I-3, page 8). A number of studies have shown that ROS are involved in the 
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 Figure I-3. The generation and function of reactive oxygen species. Reactive 
oxygen species (ROS) are generated in mitochondrion, xanthine oxidase, peroxisomes, 
NADPH oxidase, and cytochrome P450, beginning with the generation of superoxide 
(O2˙), which is rapidly converted to hydrogen peroxide (H2O2) by superoxide 
dismutase (SOD) or in a low pH environment. Hydrogen peroxide (H2O2) then is 
catalyzed to hydroxyl radical (˙OH) via Fenton reaction. The functions of ROS 
include immune defense, inflammatory activity, cellular signaling, gene expression, 
cell growth regulation, and angiogenesis. 
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developments of a variety of health disorders, including cardiovascular disease, 
cancer, neurological disorders, diabetes, ischemia/reperfusion injury, and aging 
(Dhalla 2000, Jenner 2003, Dalle-Donne 2006). Normally, several defense 
mechanisms protect cells from ROS-induced damage, one of which is antioxidant 
defense mechanism. Antioxidant defense mechanisms include enzymes such as 
superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx), and 
non-enzyme substances such as ascorbic acid (vitamin C), α-tocopherol (vitamin E), 
glutathione (GSH)/glutathione disulfide (GSSG), carotenoids, and flavonoids. Among 
them GSH/GSSG system has been considered to play a major role in defense against 
ROS (Schafer 2001) (Figure I-4, page 9). 
2GSH
H2O
GSSG
NADPH+H+NADP+
GSH peroxidase
GSSG reductase
ROOH
(H2O2 )
+ROH
(H2O )
 
Figure I-4. GSH/GSSG antioxidative system. Organic peroxides (ROOH) or 
hydrogen peroxide (H2O2) is converted to their hydroxyl form (ROH) and water, 
respectively, by glutathione (GSH) peroxidase. At the same time, two molecules of 
GSH are converted to one molecule of glutathione disulfide (GSSG) which could be 
converted back to two molecules of GSH by GSSG reductase. GSH/GSSG ratio is 
commonly used to be an indicator of oxidative stress in cells and tissues. 
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4. Brief introduction of the requirement for iron in human body and the source, 
absorption, function, and deficiency of iron 
The adult human body contains 2-4 g iron, or 38-50 mg iron/kg body weight. 
The majority (about 70%) of iron is contained in heme and hemoglobin (Ponka 1997). 
Since iron could be recycled from senescent erythrocytes, very little iron, 0.7-1.0 mg 
iron/kg body weight/day for men and postmenopausal women or 1.3-1.4 mg/kg body 
weight/day for premenopausal women, is lost (Smith 2005). The National Academy 
of Sciences, Institute of Medicine, and Food and Nutrition Board suggest that the 
Recommended Dietary Allowances (RDA) for iron are 8 mg/day for men older than 
19 years and women older than 51 years and 18 mg/day for women aged from 19 to 
50 years (The National Academies, 2001). General speaking, there are two major 
sources of iron: heme iron, which is rich in liver and organ meats, and nonheme iron, 
which is rich in nuts, dark green leafy vegetables, and dried fruits. Iron absorption 
occurs primarily in duodenum (Smith 2005). 
Iron-containing heme is released from hemoglobin or myoglobin, and is rapidly 
absorbed into enterocyte of the small intestine. In enterocyte, ferrous iron is released 
from the degradation of heme by heme oxygenase-1 (HO-1). The iron released from 
nonheme iron-containing food is in the ferric form, which is reduced to ferrous iron in 
the intestinal lumen by duodenal cytochrome b (Dcytb). Ferrous iron is then 
transported into the enterocyte of the small intestine by natural resistance associated 
macrophage protein 2 (nramp2) or one of its isoforms, divalent metal transporter 1 
(DMT1). Then, another transporter, ferroportin, exports ferrous iron, both from heme 
iron and nonheme iron, from enterocyte to circulation, followed by the oxidation of 
ferrous iron to ferric iron by hephaestin. Ferric iron in the circulation is attached to 
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transferrin which delivers iron to bone marrow or other tissues. Iron-attached 
transferrin in the circulation therefore binds to transferrin receptor (TfR) in the surface 
of tissue cells. The complex of ferric iron-binding transferrin and TfR is then 
imported to endosome via endocytosis. After being reduced to ferrous form in the acid 
environment of the endosome, iron is exported from the endosome by DMT1, and is 
used to synthesize iron-containing proteins. The extra iron is stored in ferritin which 
may bind up to 4,500 iron atoms (Pantopoulos 2004). Two iron chelators are used in 
my thesis: desferoxamine (DFO) and 2’, 2’-dipyridyl (DPD). DFO is relatively 
hydrophilic and preferentially binds to ferric iron (1:1), but DPD is hydrophobic and 
binds to ferrous iron (3:1) (Figure I-5, page 12).   
Iron functions as a component of several iron-containing proteins including 
hemoglobin/myoglobin which transports/stores oxygen, proteins involved in electron 
transport (such as cytochromes b and c, NADPH dehydrogenase, and 
ubiquinone-cytochrome c reductase), monooxygenases/dioxygenases (such as 
tyrosine monooxygenase), peroxidases (such as catalase), oxidoreductases (such as 
xanthine oxidase and dehydrogenase), and other iron-containing proteins (such as 
ribonucleotide reductase which is involved in DNA synthesis) (Smith 2005).  
However, iron deficiency is still very prevalent, and has been considered an 
international health problem influencing an estimated two billion people worldwide, 
most of which are young children and women in reproductive age, especially in 
developing countries. It was reported that the prevalence of low iron stores was  
10-19% in the U.S. females aged from 12 to 49 years in 2002 (Ramakrishnan 2002). 
The most common result of iron deficiency is iron deficiency anemia. Iron deficiency 
may also impair the performance in cognitive tasks and learning ability in children, 
12 
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Figure I-5. The absorption, transport, storage, and chelation of iron. 
Iron-containing heme is released from hemoglobin or myoglobin, and is rapidly 
absorbed into enterocyte of the small intestine. In enterocyte, ferrous iron (Fe2+) is 
released from the degradation of heme by heme oxygenase-1 (HO-1). The iron 
released from nonheme iron-containing food is in the ferric form (Fe3+), which is 
reduced to ferrous iron (Fe2+) in the intestinal lumen by duodenal cytochrome b 
(Dcytb). Ferrous iron (Fe2+) is then transported into the enterocyte by natural 
resistance associated macrophage protein 2 (nramp2) or one of its isoforms, divalent 
metal transporter 1 (DMT1). Then, another transporter, ferroportin, exports of ferrous 
iron, both from heme iron and nonheme iron, from enterocyte to circulation, followed 
by the oxidation of ferrous form iron (Fe2+) to ferric form iron (Fe3+) by hephaestin. 
Ferric iron (Fe3+) in the circulation is attached to transferrin which delivers iron to 
bone marrow or other tissues. Iron-attached transferrin in the circulation therefore 
binds to transferrin receptor (TfR) in the surface of tissue cells. The complex of ferric 
iron-binding transferrin and TfR is then imported to endosome via endocytosis. After 
being reduced to ferrous form (Fe2+) in the acid environment of the endosome, iron is 
exported from the endosome by divalent metal transporter 1 (DMT1), and is used to 
synthesize iron-containing protein. The extra iron is stored in ferritin which may bind 
to 4,500 iron atoms. Two iron chelators are used in my thesis: desferoxamine (DFO) 
and 2’, 2’-dipyridyl (DPD). Desferoxamine (DFO) is relatively hydrophilic and 
preferentially binds to ferric iron (Fe3+) (1:1), whereas 2’, 2’-dipyridyl (DPD) is 
hydrophobic and binds to ferrous iron (Fe2+) (3:1). 
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working performance and productivity in adults, and capability to maintain body 
temperature (Smith 2005). It also has been shown that iron deficiency may increase 
cadmium absorbance 5-20% (Nordberg 1985), and that low concentration of serum 
ferritin (< 12 μg/L) may increase kidney lesions caused by cadmium (Jarup 1998).  
Research problem 
As reviewed above, metals may have contrasting biological effects. Iron and 
cadmium are generally regarded as an important micronutrient and toxic 
environmental agent. Iron is an important micronutrient which has important 
functions in human bodies. However, cadmium is a contaminant and carcinogen, 
which causes damages and cancers. When exposed to cadmium, cells increase the 
expression of HO-1 to protect them against cadmium toxicity.  
Although both the importance of iron and the toxicity of cadmium are well 
known, it is not clear whether iron is required to the upregulation of HO-1 caused by 
cadmium, the defending mechanism against cadmium toxicity. To understand this 
question is important, because the answer could help to better develop an efficient 
strategy to defend against cadmium toxicity, especially in developing countries where 
both iron deficiency and cadmium exposure are prevalent. 
Thesis objective and hypothesis tested 
The objective of my thesis was to evaluate the influence of a metal micronutrient 
deficiency, iron deficiency, on cadmium-induced upregulation of HO-1 gene 
expression. My central hypothesis was that iron plays a critical role in 
cadmium-induced upregulation of HO-1 gene expression. This hypothesis was 
formulated based on the observation that iron chelator desferoxamine (DFO) 
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decreased the upregulating effect of cadmium on HO-1 activity in HCT116 human 
colon epithelial cells. The rationale of my thesis was that it was expected to provide 
some basic knowledge to better develop a strategy to protect people, especially the 
people with iron deficiency, against cadmium toxicity.  
There were two major specific aims included in my thesis. Specific aim No. 1 
was to evaluate the influence of iron deficiency on the upregulating effecs of 
cadmium on HO-1 gene expression. The working hypothesis for this specific aim was 
that iron deficiency may influence the upregulating effect of cadmium on HO-1. To 
test the hypothesis, the following two approaches were made: 1) investigating the 
influence of iron deficiency caused by iron chelators on the upregulating effect of 
cadmium on HO-1 in HCT116 cells; 2) investigating the effects of the restoration of 
iron on the upregulating effect of cadmium on HO-1 in iron-deficient cells caused by 
iron chelators. It was expected that iron deficiency caused by iron chelators would 
impair, and the treatment with iron in iron-deficient cells caused by iron chelators 
may restore, the upregulating effect of cadmium on HO-1.  
Specific aim No. 2 was to provide a possible explanation of the effects of 
cadmium on HO-1 gene expression in the cells with or without iron deficiency. The 
working hypothesis for this specific aim was that cadmium upregulates HO-1 gene 
expression by depleting intracellular glutathione and that NADPH oxidase 
(NOX)-produced ROS play an important role in cadmium-induced HO-1 upregulation. 
To test the hypothesis, the following two approaches were made: 1) comparing the 
effects of cadmium and glutathione scavengers on the intracellular glutathione and 
HO-1 gene expression; 2) investigating the influences of NOX inhibitors and 
superoxide scavenger on the upregulating effect of cadmium on HO-1. It was 
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expected that NOX-produced ROS would play an important role on cadmium-induced 
upregulation of HO-1, and that cadmium would upregulate HO-1 by depleting 
intracellular glutathione.    
My thesis was expected to provide some basic knowledge about the influence of 
iron deficiency on cadmium-induced upregulation of HO-1 and a possible explanation 
of the effects of cadmium on HO-1 gene expression in the cells with or without iron 
deficiency. The outcomes of my thesis could help people understand the mechanism 
of cadmium toxicity and better develop an efficient strategy to defend against 
cadmium toxicity, especially in a population with iron dceficiency. 
The detailed approaches obtaining the two specific aims of my thesis are 
presented in the next two chapters. 
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CHAPTER II 
THE INFLUENCE OF IRON DEFICIENCY ON CADMIUM-INDUCED 
UPREGULATION OF HEME OXYGENASE-1 IN HCT116 CELLS 
Abstract 
Metals may have contrasting biological effects. Iron and cadmium are generally 
regarded as an important micronutrient and a toxic environmental agent, respectively. 
However, it is not clear whether iron is required to help defend cells against cadmium 
toxicity. In the present study, the effects of cadmium on the cytoprotective gene, heme 
oxygenase-1 (HO-1), in HCT116 human colon epithelial cells with or without iron 
deficiency caused by iron chelators, deferoxamine (DFO) or 2’,2’-dipyridyl (DPD) 
were investigated. It was found that cadmium upregulated HO-1 mRNA, protein 
expression and enzyme activity in iron-sufficient cells, but these effects could be 
decreased by DFO. Similarly, another iron chelator, DPD, decreased the upregulating 
effects of cadmium on HO-1 mRNA and protein expression. Furthermore, it was 
found that iron, but not copper and zinc, restored the upregulating effects of cadmium 
on HO-1 mRNA and protein expression and enzyme activity in the cells pretreated 
with DFO or DPD. These results suggest that iron plays an important role in the 
defending mechanism, HO-1 upregulation, against the toxicity of cadmium or other 
potential xenobiotics. 
Introduction 
The undesirable nature of cadmium is well known. As a by-product of the mineral 
industry and a component mainly used in battery production, cadmium is one of the 
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most toxic elements in the environment (Patrick 2003). Cadmium exposure may result 
from mining, industrial emission, contaminated soil, pigments, plastic stabilizers, 
anti-corrosive products, and tobacco smoke. Plants absorb cadmium from 
cadmium-contaminated soil or water resulting in elevated cadmium concentrations in 
plant and animal products. People consuming these plant and animal products are 
more likely to suffer from cadmium exposure. Cadmium toxicity has been a health 
concern in industrial workers and populations living in polluted areas, especially in 
developing countries (Sethi 2006). Cadmium may be absorbed from respiratory tract 
and gastrointestinal tract. Due to its long half-life, the accumulation of cadmium in 
human body is irreversible. Cadmium has been shown to cause kidney dysfunction, 
bone deformation, obstructive lung disease, hypertension, and cancers of lung, 
prostate, breast, and pancreas (Akesson 2005, Jin 2004, Satarug 2004, Shukla 2000, 
Ekman 1999, Coyle 2004, Schwartz 2000). The basic mechanisms of cadmium 
toxicity are not fully understood. However, cadmium has been shown to have the 
property to induce the production of reactive oxygen species (ROS), causing 
dysfunction of mitochondria, lipid peroxidation of cell membrane, and DNA damage 
(O’Brien 1998, Stohs 2001).  
Heme oxygenase-1 (HO-1), one isoform of heme oxygenase (HO), the 
rate-limiting enzyme in the degradation of heme, has captured lots of interests for 
decades because of its protective functions including antioxidative and 
anti-inflammatory effects (Morse 2002). The expression of HO-1 can be upregulated 
by various forms of stress, one of which is the exposure to cadmium (Poss 1997, 
Taketani 1989, Yachie 1999).  
In contrast, iron has been well known as a vital micronutrient for good health, 
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participating in the utilization of oxygen and being an important component of 
numerous iron-containing proteins which are involved in oxygen transport and storage, 
electron transport, and DNA synthesis. However, iron deficiency is still one of the 
most prevalent nutritional disorders worldwide, affecting an estimated 2 billion 
people, causing iron deficiency anemia, worsening fatigue, and other health problems, 
especially in developing countries (Smith 2005, Ramakrishnan 2002). 
Both cadmium exposure and iron deficiency are prevalent in developing countries. 
However, it is unclear whether iron is required to help protect humans against 
cadmium exposure. The interaction between cadmium and iron at the cellular level is 
not totally understood due to inadequate research in this area. In the present study, the 
effects of cadmium on HO-1 in HCT116 cells with or without iron deficiency were 
investigated. It was found that cadmium upregulated HO-1 mRNA and protein 
expression and enzyme activity in iron-sufficient HCT116 cells. However, these 
effects could be decreased in iron-deficient cells caused by the pretreatments with iron 
chelators, desferoxamine (DFO) or 2’,2’-dipyridyl (DPD). Interestingly, the treatment 
with iron sulfate, but not zinc sulfate and copper sulfate, restored the upregulating 
effects of cadmium on HO-1 mRNA and protein expression and enzyme activity in 
iron-deficient cells caused by DFO or DPD. These results suggest that iron may play a 
critical role in the cadmium-induced upregulation of HO-1. 
Materials and methods 
1. Materials 
HCT116 human colon adenocarcinoma cell line was purchased from the 
American Type Culture Collection (Manassas, VA). Anti-HO-1 was from Santa Cruz 
Biotechnology (Santa Cruz, CA). Cadmium chloride, McCOY’s 5A cell culture 
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media and other reagents were purchased from Sigma-Aldrich Company (St. Louis, 
MO). 
2. Cell culture and treatments  
HCT116 cells were grown in McCOY’s 5A cell culture media (Sigma-Aldrich, 
MO) in a humidified atmosphere of 5% carbon dioxide (CO2), 95% air at 37 ºC, with 
the supplement of 2.2 g/L sodium bicarbonate (Sigma-Aldrich, MO), 11.5 ml/L 
penicillin/streptomycin solution (Lonza, MD), 4.1 ml/L amphotericin B (Mediatech, 
VA), and 113 ml/L fetal bovine serum (Mediatech, VA). After reaching a confluence 
of 80%, depending on the experiments, the cells were: 1) exposed to 0-50 μM 
cadmium chloride for 5 hours; 2) pretreated with 0-100 μM desferoxamine (DFO) or 
2’,2’-dipyridyl (DPD) for 24 hours, followed by the exposure to 0-50 μM cadmium; 3) 
treated with 0-50 μM desferoxamine (DFO) (Sigma-Aldrich, MO), or 2’, 2’-dipyridyl 
(DPD) (Sigma-Aldrich, MO) for 24 hours, followed by the treatment with 0-100 μM 
iron sulfate (FeSO4) (Mallinckrodt Chemical Works, NY) for 3 hours before the 
exposure to 0-50 μM cadmium for 5 hours; 4) treated with 0-50 μM DFO for 24 hours 
followed by the treatment with 0-100 μM FeSO4, copper sulfate (CuSO4) (Fisher 
Scientific, NJ), or zinc sulfate (ZnSO4) (Baker Analyzed, NJ) for 3 hours before the 
exposure to 0-50 μM cadmium for 5 hours.  
3. Determination of HO-1 mRNA expression 
The cells were harvested and centrifuged at 500 rpm for 5 minutes. Total RNA 
was isolated from the cells by using a Qiagen RNeasy Mini kit (Qiagen, CA). The 
HO-1 mRNA expression was determined by reverse transcription polymerase chain 
reaction (RT-PCR) analysis using a Qiagen OneStep RT-PCR kit (Qiagen, CA) and 
HO-1 primers (Qiagen, CA). The HO-1 PCR upper and lower primer sequences were: 
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5’-TGTGGCAGCTGTCTCAAACCTCCA-3’ and 
5’-TTGAGGCTGAGCCAGGAACAGAGT-3’. The β-actin QuantumRNA 
primer/competimer sets (Ambion, TX) were used as internal standard. The RT-PCR 
conditions were 30 minutes at 50 °C, followed by 15 minutes at 95 °C (RT), then 0.5 
minutes at 95 °C, 0.5 minutes at 60 °C, and 1 minute at 72 °C (PCR) for 25 cycles. 
The resulting cDNA products were separated by electrophoresis in 2% agarose gel 
with ethidium bromide staining. For the target gene (HO-1), the PCR product size was 
175 base pairs (bp). For the internal control, β-actin, the PCR product size was 294 
bp. 
4. Western immunoblotting analysis of HO-1 protein 
The cells were harvested, washed and centrifuged in 500 rpm for 5 minutes in 
phosphate buffered saline (PBS). The cells were then lysed using 
radioimmunoprecipitation assay (RIPA) buffer (PBS, 1% Nonidet P-40, 0.5% sodium 
deoxycholate, 0.1% sodium dodecyl sulfate, and Roche Complete Protease Inhibitor 
Cocktail, pH 7.4) and sat on ice for 30 minutes. Then, the cell lysate was centrifuged 
at 15,000 rpm for 20 minutes at 4 °C, and the supernatant was saved. The protein 
concentration of the supernatant was determined using a BCA protein assay kit 
(Pierce, IL). Then the cell lysate supernatant (100 μg protein) was electrophoresed 
using Novex NuPAGE (Invitroge, CA) mini-gels (4-12% Bis-Tris) in NuPAGE 
MOPS SDS Running Buffer (Invitrogen, CA), followed by blotting the gel to a 
nitrocellulose membrane. Blotting was performed for 1 hour at 25 °C in NuPAGE 
Transfer Buffer (Invitrogen, CA). The membrane was incubated overnight at 4 °C 
with HO-1 goat monoclonal antibody (Santa Cruz, CA) in blocking buffer consisting 
of 5% skim milk powder in TBST (20 mM Tris-HCl, 150 mM sodium chloride, 
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0.05% Tween 20, pH 7.4) (1:1,000). After being washed three times with TBST for 
30 minutes, the membrane was incubated for 2 hours at 25 °C with rabbit anti-goat 
IgG/HRP conjugate (Santa Cruz, CA) in blocking buffer (1:100,000). Finally, after 
being washed again, the membrane was placed in a plastic pouch for incubation with 
Thermo Scientific Super Signal West Femto Luminol/Enhancer Solution (Thermo 
Scientific, IL) for 5 minutes before analysis (Kodak digital scienceTM image station 
440 CF). Then the membrane was washed with Restore Western Blot Stripping Buffer 
(Thermo Scientific, IL) and incubated with mouse monoclonal anti-β-actin antibody 
in blocking buffer (1:40,000) for 2 hours at 25 °C. After being washed three times 
with TBST for 30 minutes, the membrane was incubated with HRP-conjugated goat 
polyclonal anti-mouse IgG (Santa Cruz, CA) in blocking buffer (1:200,000) for 1 hour 
at 25 °C. Then, the membrane was washed in TBST and processed for analysis as 
before. 
5. Determination of HO-1 enzyme activity 
The cells were harvested, washed and centrifuged at 500 rpm for 5 minutes in 
4 °C PBS. Cell pellets were resuspended in 100 mM phosphate buffer containing 2 
mM magnesium chloride (MgCl2), and were sonicated. After being spun at 15,000 
rpm for 10 minutes at 4 °C, the supernatant was saved and protein in the supernatant 
was determinated. Then 0.8 mg protein was used to quantitate HO-1 enzyme activity 
in a reaction volume of 1 ml, containing 0.1 ml liver cytosol, 1 mM NADPH, 0.25 
mM hemin, 2 mM glucose-6-phosphate, and 0.002 U/μL glucose-6-phosphate 
dehydrogenase. The reaction was performed at 37 °C for 1 hour in the dark and 
stopped by adding 1 ml of chloroform. The tubes were vortexed thoroughly followed 
by centrifugation at 500 rpm for 5 minutes. Finally, the chloroform layers were 
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measured for the absorbance of a visible light at 464 nm with the background at 530 
nm in a spectrophotometer. The HO-1 enzyme activity was expressed as formation of 
pmol bilirubin per hour per milligram of protein. 
6. Statistical analysis 
HO-1/β-actin mRNA ratio and HO enzyme activity data were analyzed via 
two-tailed unpaired t test using SPSS 16.0 for Microsoft Windows XP (SPSS Inc., 
IL).  
Results 
1. Cadmium upregulated HO-1 mRNA and protein expression in iron-sufficient 
HCT116 cells 
To investigate the effect of cadmium on the expression of HO-1, the cells were 
exposed to 0-50 μM cadmium chloride for 5 hours. It was found that HO-1 mRNA 
was constitutively expressed at a relative low level in control cells (0 μM cadmium), 
and the treatments with 10-50 μM cadmium increased HO-1 mRNA expression 
(Figure II-1 B, page 42); the fold increase of HO-1 mRNA/β-actin mRNA ratios in the 
cells treated with cadmium appeared to be dose-dependent manner (p<0.05) (Figure 
II-1 A, page 42); similarly, the treatments with cadmium increased HO-1 protein 
expression (Figure II-1 C, page 42).  
2. Cadmium upregulated HO-1 enzyme activity, and this effect could be decreased by 
an iron chelator, desferoxamine (DFO)  
It was also found that as depicted in Figure II-2 (page 43), HO-1 enzyme activity 
was relative low in control cells; the treatment with cadmium dramatically increased 
HO-1 enzyme activity; the pretreatments with 25-50 μM DFO significantly decreased 
the upregulating effect of cadmium on HO-1 enzyme activity (p<0.05). 
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3. DFO decreased the upregulating effects of cadmium on HO-1 protein and mRNA 
expression  
Because the pretreatment of DFO led to a decreased upregulating effect of 
cadmium on HO-1 enzyme activity, we managed to determine if HO-1 protein and 
mRNA were also decreased. The cells were pretreated with 0-100 μM DFO for 24 
hours, followed with or without the exposure to 0-50 μM cadmium for 5 hours. It was 
found that the treatment with 50 μM cadmium increased HO-1 protein expression, 
and pretreatment with 25-100 μM DFO decreased the upregulating effect of cadmium 
on HO-1 protein expression (Figure II-3 C, page 44). Furthermore, it was found that 
HO-1 mRNA was expressed at a relative low level in control cells (0 μM cadmium 
and 0 μM DFO), and the treatment with 50 μM cadmium increased HO-1 mRNA 
expression; however, the pretreatments with 25-100 μM DFO decreased the 
upregulating effect of cadmium on HO-1 mRNA (Figure II-3 B, page 44); the ratio of 
HO-1 mRNA/β-actin mRNA in the cells treated with 50 μM cadmium was increased 
dramatically compared to the control cells, but the ratios of HO-1 mRNA/β-actin 
mRNA in the cells treated with 25-100 μM DFO and 50 μM cadmium were 
significantly decreased compared to the cells treated with 50 μM cadmium (p<0.05) 
(Figure II-3 A, page 44).  
4. Another iron chelator, 2’,2’-dipyridyl (DPD), decreased the upregulating effects of 
cadmium on HO-1 protein and mRNA expression 
To confirm that the decreased upregulating effects of cadmium on HO-1 protein 
and mRNA expression was caused by iron deficiency, several additional experiments 
were conducted. First, the effect of another iron chelator, 2’,2’-dipyridyl (DPD), on 
the upregulating effects of cadmium on HO-1 protein and mRNA was tested. Cells 
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were pretreated with 0-100 μM DPD for 24 hours, followed with or without the 
exposure to 0-50 μM cadmium for 5 hours. It was found that HO-1 mRNA was 
constitutively expressed at a relative low level in control cells (0 μM cadmium and 0 
μM DPD), and the treatment with 50 μM cadmium increased HO-1 mRNA expression; 
however, the pretreatments with 50-100 μM DPD decreased the upregulating effect of 
cadmium on HO-1 mRNA (Figure II-4 B, page 46); the ratio of HO-1 mRNA/β-actin 
mRNA in the cells treated with 50 μM cadmium was dramatically increased compared 
to the control cells, but the ratios of HO-1 mRNA/β-actin mRNA in the cells treated 
with 50-100 μM DPD and 50 μM cadmium were significantly decreased compared to 
the cells treated with 50 μM cadmium (p<0.05) (Figure II-4 A, page 46); similarly, the 
treatment with 50 μM cadmium increased HO-1 protein expression, and the 
pretreatments with 10-100 μM DPD decreased the upregulating effect of cadmium on 
HO-1 protein expression (Figure II-4 C, page 46). 
5. Iron restored the upregulating effects of cadmium on HO-1 protein and mRNA 
expression in the cells pretreated with DFO or DPD  
Next, experiments were conducted to investigate whether iron could restore the 
upregulating effects of cadmium on HO-1 protein and mRNA in the cells pretreated 
with DFO or DPD. Cells were treated with 0-100 μM iron sulfate (FeSO4) for 3 hours 
after the pretreatment with 0-50 μM DFO or DPD for 24 hours, then cells were 
exposed to 0-50 μM cadmium for 5 hours. It was found that the treatments with 
50-100 μM FeSO4 restored the upregulating effect of cadmium on HO-1 mRNA 
expression in the cells pretreated with 50 μM DFO (Figure II-5 B, page 48) or DPD 
(Figure II-6 B, page 50), respectively; the ratios of HO-1 mRNA/β-actin mRNA was 
significantly increased in the cells treated with DFO, 50-100 μM FeSO4, and 
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cadmium compared to the cells treated with DFO and cadmium (p<0.05) (Figure II-5 
A, page 48); similarly, the ratios of HO-1 mRNA/β-actin mRNA were significantly 
increased in the cells treated with DPD, 100 μM FeSO4, and cadmium compared to 
the cells treated with DPD and cadmium (p<0.05) (Figure II-6 A, page 50); 
furthermore, the treatments with 50-100 μM FeSO4 restored the upregulating effect of 
cadmium on HO-1 protein expression in the cells pretreated with 50 μM DFO (Figure 
II-5 C, page 48) or DPD (Figure II-6 C, page 50).   
6. Iron, but not copper and zinc, restored the upregulating effect of cadmium on HO-1 
mRNA expression in the cells pretreated with DFO 
Considering DFO can also chelate other metals such as copper and zinc, the 
effects of the treatments iron, copper, or zinc on the upregulating effect of cadmium 
on of HO-1 mRNA expression in the cells pretreated with DFO were compared. Cells 
were pretreated with 0-50 μM DFO for 24 hours, followed the treatment with 0-100 
μM iron sulfate (FeSO4), copper sulfate (CuSO4), or zinc sulfate (ZnSO4) for 3 hours, 
and then cells were exposed to 0-50 μM cadmium for 5 hours. It was found that the 
treatment with 100 μM FeSO4 restored the upregulating effect of cadmium on HO-1 
mRNA expression in the cells pretreated with 50 μM DFO; however, no restoring 
effect of the treatments with CuSO4 or ZnSO4 on the upregulating effect of cadmium 
on HO-1 mRNA was observed in the cells pretreated DFO (Figure II-7 B, page 52); 
the ratio of HO-1 mRNA/β-actin mRNA was significantly increased in the cells 
treated with DFO, FeSO4, and cadmium compared to the cells treated with DFO and 
cadmium (p<0.05); but the ratios of HO-1 mRNA/β-actin mRNA in the cells treated 
with DFO, CuSO4 or ZnSO4, and cadmium were not different from in the cells treated 
with DFO and cadmium (Figure II-7 A, page 52). 
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7. Iron restored the upregulating effect of cadmium on HO-1 enzyme activity in the 
cells pretreated with DFO 
Finally, the effect of iron on the upregulating effect of cadmium on HO-1 enzyme 
activity in the cells pretreated with DFO was tested. Cells were pretreated with or 
without 0-50 μM DFO for 24 hours, followed with the treatments with or without 
0-100 μM FeSO4 for 3 hours. Then the cells were exposed to 50 μM cadmium for 5 
hours. It was found that the treatment with FeSO4 significantly restored the 
upregulating effect of cadmium on HO-1 enzyme activity (p<0.05) (Figure II-8, page 
54). 
Discussion 
In the present study, the results indicate that cadmium upregulated HO-1 mRNA 
and protein expression and enzyme activity in iron-sufficient HCT116 cells (Figure 
II-1 and 2, page 42-43), which is consistent with other scientists’ work (Taketani 1989, 
Gong 1997). In the Taketani study, they found that the exposure to cadmium or 
arsenite upregulated a 32-kDa HO protein expression and enzyme activity in HeLa 
and HL 60 cells. Similarly, the Gong group found that the exposure to cadmium 
upregulated the expression HO-1 as well as other genes in rat lung epithelial cells. 
One of the mechanisms of the toxicity of cadmium has been believed to cause the 
intracellular accumulation of ROS (O’Brien 1998, Stohs 2001). In fact, it is 
considered to be critical for cells exposed to cadmium to be able to fully express 
HO-1 to help defend against oxidative stress. Actually, some adverse effects of HO-1 
deficiency have been shown in vivo and in vitro. In 1999, a persistent endothelial 
damage caused by oxidative stress was reported in a six-year old patient with HO-1 
deficiency (Yachie 1999). Also, an increased production of free radicals was observed 
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in HO-1 deficient embryonic fibroblasts exposed to cadmium, and these cells were 
more sensitive to hemin- or hydrogen peroxide-caused cytotoxicity (Poss 1997). 
Studies have shown that the anti-oxidative property of HO-1 may come from the 
following facts: first, HO-1 degrades the pro-oxidant heme, resulting in a decrease of 
heme and an increase of iron; second, iron release from heme may induce the 
production of ferritin (Vile 1994), which may in turn sequester free iron and reduce 
the overall intracellular oxidant status; finally, biliverdin and bilirubin, two other 
products of heme degradation which were considered as waste products, have been 
shown to have potent antioxidant properties (Stocker 1987, Neuzil 1993).     
Interestingly, it was observed in the present study that the iron chelator DFO 
decreased the upregulating effects of cadmium on HO-1 mRNA and protein 
expression and enzyme activity (Figure II-2 and 3, page 43-44). These results suggest 
that iron may be playing a critical role in the increased expression of HO-1 caused by 
cadmium. Similar results were observed by Fogg et al. (Fogg 1999). In their study 
(Fogg 1999), they found that pretreatment with DFO to human pulmonary artery 
endothelial cells decreased the upregulated expression of HO-1 mRNA caused by the 
exposure to hyperoxia, specially to heme and free iron, and concluded that iron plays 
a critical role in regulating HO-1 expression caused by hyperoxia. Their study focused 
on the effect of DFO on HO-1 expression in the cells with iron overload caused by the 
treatment with heme and free iron. Hence they were interested in finding out if iron 
toxicity could be reduced by DFO, instead of studying cellular iron deficiency caused 
by DFO. The present study focused on the effect of cadmium on HO-1 expression in 
iron-deficient cells caused by the treatment with DFO. Furthermore, the conclusion of 
Fogg study was not entirely persuasive because as mentioned above, besides iron, 
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DFO also has the property to chelate other metals such as zinc and copper. In the 
present study, three additional experiments were conducted to confirm the iron role in 
the upregulation of HO-1 caused by cadmium. First, the effect of another iron chelator, 
DPD, on the upregulating effects of cadmium on HO-1 mRNA and protein expression 
were investigated. It was observed that DPD, similar to DFO, decreased the 
upregulating effects of cadmium on HO-1 mRNA and protein expression (Figure II-4, 
page 46). Second, after the pretreatments with DFO or DPD and before the exposure 
to cadmium, the cells were treated with iron, and it was found that the treatment with 
iron restored the upregulating effects of cadmium on HO-1 mRNA and protein 
expression and enzyme activity in the cells pretreated with DFO or DPD (Figure II-5 
and 6, page 48-50; Figure II-8, page 54). Finally, after the pretreatment with DFO, the 
cells were treated with iron, zinc, or copper, and it was found that only iron, but not 
zinc and copper, restored the upregulating effect of cadmium on HO-1 mRNA 
expression in the cells pretreated with DFO (Figure II-7, page 52). Put together, the 
results strongly suggest that iron plays a critical role in the cadmium-induced 
upregulation of HO-1. 
As discussed before, cadmium may cause intracellular accumulation of ROS. 
However, the mechanism is not well demonstrated. Because cadmium is not a 
redox-active metal, it is not able to generate ROS itself. Some researchers proposed 
that cadmium increases the cellular ROS level via indirect processes, including 
inhibiting the electron transfer chain in mitochondrion (Latinwo 2006, Wang 2004) 
and decreasing cellular antioxidants (Stohs 1995). Some others have shown that 
cadmium may replace zinc, iron and copper from enzymes or proteins disturbing the 
cellular balance of these metals, hence resulting in the generation of ROS (Block 1992, 
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Fotakis 2006). 
ROS includes superoxide, hydroxyl radical and hydrogen peroxide which are 
by-products of oxygen metabolism and could be generated in response to extraneous 
stimuli. Furthermore, ROS could be generated from several different sources 
including mitochondrion, xanthine oxidase, peroxisomes, and cytochrome P450. 
Among them, mitochondrion and NADPH oxidase have been considered two major 
sources of ROS (Fleury 2002, Lambeth 2004).  
Iron deficiency caused by DFO and DPD decreased the upregulating effects of 
cadmium on the enzyme activity and the expression of protein and mRNA of HO-1, 
indicating a modulation at a pre-transcriptional level, very likely by interrupting the 
production of ROS in the two major sources, mitochondrion, or NAPDH oxidase. 
Since NADPH oxidase (NOX) contains two hemes participating in the electron 
transport in the enzyme (Finegold 1996), then it is possible that iron chelators, DFO 
and DPD, deplete the iron in the heme, a component of NOX, affecting the electron 
transport in the enzyme and reducing the production of ROS, therefore decrease the 
upregulating effect of cadmium on HO-1. 
In conclusion, the present study shows that cadmium upregulated HO-1 mRNA 
and protein expression and enzyme activity in iron-sufficient HCT116 cells. However, 
these upregulating effects could be decreased and be restored by the treatment with 
iron, but not copper and zinc, in iron-deficient cells caused by the pretreatments with 
iron chelators, DFO or DPD. These observations suggest that iron plays an important 
role to the upregulation of HO-1 by cadmium, which has been thought to be a 
defending mechanism against cadmium toxicity. These observations imply that with 
cadmium exposure, population with iron deficiency could have a higher risk to 
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develop adverse health problems than iron-sufficient population. 
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Figure II-1. Cadmium upregulated HO-1 mRNA and protein expression in 
iron-sufficient HCT116 cells. Cells were treated with 0-50 μM cadmium for 5 hours. 
B: HO-1 mRNA was constitutively expressed in control cells, and the treatments with 
10-50 μM cadmium increased HO-1 mRNA expression. A: the ratios of HO-1 
mRNA/β-actin mRNA were increased in the cells treated with 10-25 μM cadmium, 
and this increasing effects appeared to be a dose-dependent manner (p<0.05). C: 
similarly, the treatments with cadmium increased HO-1 protein expression. The 
values given are means ± S.E.M. from three independent experiments (*, the 
treatments with 10, 25, or 50 μM cadmium vs. control, p<0.05). 
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Figure II-2. Cadmium upregulated HO-1 enzyme activity, and this effect could be 
decreased by desferoxamine. Cells were pretreated with 0-50 μM desferoxamine 
(DFO) for 24 hours, followed by the exposure to 0-50 μM cadmium for 5 hours. 
HO-1 enzyme activity was relative low in control cells. The treatment with 50 μM 
cadmium increased HO-1 enzyme activity. The pretreatments with 25-50 μM DFO 
significantly decreased the upregulating effect of cadmium on HO-1 enzyme activity 
(p<0.05). The values given are means ± S.E.M. from three independent experiments 
(*, the treatments with 25 or 50 μM DFO plus 50 μM cadmium vs. the treatment with 
0 μM DFO plus 50 μM cadmium, p<0.05). 
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Figure II-3. DFO decreased the upregulating effects of cadmium on HO-1 
protein and mRNA expression. Cells were treated with 0-100 μM DFO for 24 hours, 
followed with or without the exposure to 0-50 μM cadmium for 5 hours. B: HO-1 
mRNA was constitutively expressed in control cells, and the treatment with 50 μM 
cadmium increased HO-1 mRNA expression; however, the pretreatments with 25-100 
μM DFO decreased the upregulating effect of cadmium on HO-1 mRNA expression. 
A: the ratio of HO-1 mRNA/β-actin mRNA in the cells treated with 50 μM cadmium 
was dramatically increased compared to the control cells; however, the ratios of HO-1 
mRNA/β-actin mRNA in the cells treated with 25-100 μM DFO and 50 μM cadmium 
were significantly decreased compared to the cells treated with 50 μM cadmium 
(p<0.05). C: similarly, the treatment with 50 μM cadmium increased HO-1 protein 
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expression, and the pretreatments with 25-100 μM DFO decreased the upregulating 
effect of cadmium on HO-1 protein expression. The values given are means ± S.E.M. 
from three independent experiments (*, the treatments with 25, 50, or 100 μM DFO 
plus 50 μM cadmium vs. the treatment with 0 μM DFO plus 50 μM cadmium, 
p<0.05). 
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Figure II-4. DPD decreased the upregulating effects of cadmium on HO-1 
protein and mRNA expression. Cells were treated with 0-100 μM DPD for 24 hours, 
followed with or without the exposure to 0-50 μM cadmium for 5 hours. B: HO-1 
mRNA was constitutively expressed in control cells, and the treatment with 50 μM 
cadmium increased HO-1 mRNA expression; however, the pretreatments with 50-100 
μM DPD decreased the upregulating effect of cadmium on HO-1 mRNA expression. 
A: the ratio of HO-1 mRNA/β-actin mRNA in the cells treated with 50 μM cadmium 
was increased dramatically compared to the control cells; however, the ratios of HO-1 
mRNA/β-actin mRNA in the cells treated with 50-100 μM DPD and 50 μM cadmium 
were significantly decreased compared to the cells treated with 50 μM cadmium 
(p<0.05). C: similarly, the treatment with 50 μM cadmium increased HO-1 protein 
expression, and the pretreatments with 10-100 μM DPD decreased the upregulating 
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effect of cadmium on HO-1 protein expression. The values given are means ± S.E.M. 
from three independent experiments (*, the treatments with 50 or 100 μM DPD plus 
50 μM cadmium vs. the treatment with 0 μM DPD plus 50 μM cadmium, p<0.05). 
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Figure II-5. Iron restored the upregulating effects of cadmium on HO-1 protein 
and mRNA expression in the cells pretreated with DFO. Cells were treated with 0-100 
μM iron sulfate (FeSO4) for 3 hours after the pretreatment with 0-50 μM DFO for 24 
hours, then cells were exposed to 0-50 μM cadmium for 5 hours. B: the treatments 
with 50-100 μM FeSO4 restored the upregulating effect of cadmium on HO-1 mRNA 
expression in the cells pretreated with 50 μM DFO. A: the ratios of HO-1 
mRNA/β-actin mRNA was significantly increased in the cells treated with DFO, 
50-100 μM FeSO4, and cadmium compared to the cells treated with DFO and 
cadmium (p<0.05). C: the treatment with 50-100 μM FeSO4 restored the upregulating 
effect of cadmium on HO-1 protein expression in the cells pretreated with 50 μM 
DFO. The values given are means ± S.E.M. from three independent experiments (*, 
the treatments with 50 μM DFO, 50 or 100 μM FeSO4, and 50 μM cadmium vs. the 
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treatments with 50 μM DFO, 0 μM FeSO4, and 50 μM cadmium, p<0.05). 
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Figure II-6. Iron restored the upregulating effects of cadmium on HO-1 protein 
and mRNA expression in the cells pretreated with DPD. Cells were treated with 0-100 
μM iron sulfate (FeSO4) for 3 hours after the pretreatment with 0-50 μM DPD for 24 
hours, and then cells were exposed to 0-50 μM cadmium for 5 hours. B: the treatment 
with 100 μM FeSO4 restored the upregulating effect of cadmium on HO-1 mRNA 
expression in the cells pretreated with 50 μM DPD. A: the ratios of HO-1 
mRNA/β-actin mRNA was significantly increased in the cells treated with DPD, 100 
μM FeSO4, and cadmium compared to the cells treated with DPD and cadmium 
(p<0.05). C: the treatment with 100 μM FeSO4 restored the upregulating effect of 
cadmium on HO-1 protein expression in the cells pretreated with 50 μM DPD. The 
values given are means ± S.E.M. from three independent experiments (*, the 
treatments with 50 μM DPD, 100 μM FeSO4, and 50 μM cadmium vs. the treatments 
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with 50 μM DPD, 0 μM FeSO4, and 50 μM cadmium, p<0.05). 
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Figure II-7. Iron, but not copper and zinc, restored the upregulating effect of 
cadmium on HO-1 mRNA expression in the cells pretreated with DFO. Cells were 
pretreated with 0-50 μM DFO for 24 hours, followed the treatment with 0-100 μM 
FeSO4, copper sulfate (CuSO4), or zinc sulfate (ZnSO4) for 3 hours, and then cells 
were exposed to 0-50 μM cadmium for 5 hours. B: the treatment with 100 μM FeSO4 
restored the upregulating effect of cadmium on HO-1 mRNA expression in the cells 
pretreated with 50 μM DFO; however, no restoring effect of the treatments with 
CuSO4 or ZnSO4 on the upregulating effect of cadmium on HO-1 mRNA was 
observed in the cells pretreated DFO. A: the ratio of HO-1 mRNA/β-actin mRNA was 
significantly increased in the cells treated with DFO, FeSO4 and cadmium compared 
to the cells treated with DFO and cadmium (p<0.05); but the ratios in the cells treated 
with DFO, CuSO4 or ZnSO4, and cadmium were similar to the cells treated with DFO 
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and cadmium. The values given are means ± S.E.M. from three independent 
experiments (*, the treatments with 50 μM DFO, 100 μM FeSO4, 0 μM CuSO4, 0 μM 
ZnSO4, and 50 μM cadmium vs. the treatments with 50 μM DFO, 0 μM FeSO4, 0 μM 
CuSO4, 0 μM ZnSO4, and 50 μM cadmium, p<0.05). 
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Figure II-8. Iron restored the upregulating effect of cadmium on HO-1 enzyme 
activity in the cells pretreated with DFO. Cells were pretreated with without 0-50 μM 
DFO for 24 hours, followed by treatments with or without 0-100 μM FeSO4 for 3 
hours. Then the cells were exposed to 0-50 μM cadmium for 5 hours. The treatment 
with FeSO4 significantly restored the upregulating effect of cadmium on HO-1 
enzyme activity (p<0.05). The values given are means ± S.E.M. from three 
independent experiments (*, the treatments with 50 μM DFO, 100 μM FeSO4, and 50 
μM cadmium vs. the treatments with 50 μM DFO, 0 μM FeSO4, and 50 μM cadmium, 
p<0.05). 
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CHAPTER III 
ELUCIDATION OF CADMIUM-INDUCED UPREGULATION OF HEME 
OXYGENASE-1 IN HCT116 CELLS 
Abstract 
As reported previously, cadmium upregulated mRNA and protein expression and 
enzyme activity of the cytoprotective gene, heme oxygenase-1 (HO-1), in 
iron-sufficient HCT116 cells, but these upregulating effects could be weakened and 
then be restored by the treatments with iron in iron-deficient cells caused by iron 
chelators, desferoxamine (DFO) or 2’, 2’-dipyridyl (DPD), indicating that iron plays a 
critical role in cadmium-induced HO-1 upregulation. In the present study, experiments 
were conducted to help explain these observations. It was found that cadmium, 
ethacrynic acid (EA), and buthionine sulfoximine (BSO) decreased intracellular 
glutathione levels. Cadmium and EA, but not BSO, increased HO-1 mRNA 
expression. EA also increased HO-1 protein expression. However, the upregulation of 
HO-1 protein and mRNA caused by cadmium or EA could be decreased by adding 
glutathione (GSH) or N-acetyl-cysteine (NAC) into the cell culture media before the 
treatments with cadmium or EA. Cadmium and EA, but not BSO, increased nuclear 
expression of nuclear factor erythroid-2 related factor 2 (Nrf-2). Furthermore, it was 
found that HCT116 cells express NADPH oxidase (NOX)-1, and NOX inhibitors, 
apocynin and diphenyleneiodonium (DPI), or superoxide anion scavenger, tiron, 
decreased cadmium-induced upregulation of HO-1 protein and mRNA expression and 
enzyme activity. Finally, it was found that DPI, but not apocynin and tiron inhibited  
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NADPH:cytochrome P450 reductase (NCPR) enzyme activity. Put together, these 
results suggest that cadmium may deplete intracellular glutathione resulting in the 
intracellular accumulation of NOX-produced ROS, which may cause the translocation 
of Nrf-2 into nucleus, therefore upregulate HO-1 expression; iron chelators DFO and 
DPD may deplete the iron in the hemes, the components of NOX, therefore decrease 
the production of NOX-produced ROS and finally attenuate the upregulating effects 
of cadmium on HO-1. 
Introduction 
Cadmium is widely used in several industrial settings, causes a variety of adverse 
health effects including carcinogenesis (Patrick 2003). As for the mechanism, 
oxidative stress induced by cadmium seems to be involved. Studies have shown that 
cadmium has the property to induce the intracellular accumulation of reactive oxygen 
species (ROS) which may cause lipid peroxidation of cell membrane and DNA 
damage (O’Brien 1998, Stohs 2001). Cadmium has also been shown to have the 
ability to upregulate the expression of a variety of stress-response genes including 
heme oxygenase-1 (HO-1), which has been believed to be an important defending 
mechanism against cadmium toxicity. 
It has been shown that HO-1, the rate-limiting enzyme in heme degradation 
(Taketani 1989), could be induced by oxidative stress (Applegate 1992) and that 
cadmium has the property to induce the intracellular accumulation of reactive oxygen 
species (ROS) by interrupting intracellular anti-oxidative system (Stohs 2001). 
Studies also have shown that ROS could be generated from several different sources 
including mitochondrion, NADPH oxidase, cytochrome P450, and other enzymes. 
Among them, mitochondrion and NADPH oxidase have been considered two major 
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sources of ROS (Fleury 2002, Lambeth 2004). It is important to note that iron is 
commonly required by these ROS-generating systems for the function of electron 
transport. 
Previously, we observed that cadmium upregulated HO-1 protein and mRNA 
expression and enzyme activity in HCT116 human colon epithelial cells, but all of 
these effects could be decreased and then be restored by the treatment with iron 
sulfate, in iron-deficient cells caused by iron chelators, desferoxamine (DFO) or 
2’,2’-dipyridyl (DPD), indicating that iron plays an important role in the 
cadmium-induced upregulation of HO-1. Experiments were conducted to help explain 
the observations.  
It was found that cadmium, ethacrynic acid (EA), and buthionine sulfoximine 
(BSO) decreased intracellular glutathione. However, only cadmium and EA, but not 
BSO, upregulated the expression of HO-1 mRNA and the nuclear expression of 
nuclear transcription factor erythroid-2 related factor 2 (Nrf-2). The upregulation of 
HO-1 mRNA by cadmium and EA could be decreased by adding GSH and NAC into 
cell culture media before the treatments with cadmium and EA. HCT116 cells 
expressed NADPH oxidase (NOX)-1 and NOX inhibitors, apocynin and 
diphenyleneiodonium (DPI), and superoxide scavenger, tiron, decreased the 
upregulating effects of cadmium on HO-1 mRNA and protein expression and enzyme 
activity. DPI, but not apocynin and tiron, also inhibited NADPH:cytochrome P450 
reductase (NCPR) enzyme activity which may further explain its potent inhibiting 
effect on HO-1 enzyme activity. These results suggest that cadmium may deplete 
intracellular glutathione, resulting in the intracellular accumulation of NOX-produced 
ROS which may cause the translocation of Nrf-2 into nucleus, therefore upregulate 
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HO-1 expression; iron chelators, DFO and DPD, may deplete the iron in the hemes, 
the components of NOX, therefore decrease the production of NOX-produced ROS 
and finally decreased cadmium-induced upregulation of HO-1. 
Materials and methods 
1. Materials 
HCT116 human colon adenocarcinoma cell line was purchased from the 
American Type Culture Collection (Manassas, VA). Anti-HO-1 was from Santa Cruz 
Biotechnology (Santa Cruz, CA). Cadmium chloride, McCOY’s 5A cell culture 
media and other reagents were purchased from Sigma-Aldrich Company (St. Louis, 
MO). 
2. Cell culture and treatments  
HCT 116 cells are grown in McCOY’s 5A cell culture media (Sigma-Aldrich, 
MO) in a humidified atmosphere of 5% CO2, 95% air at 37 ºC, with the supplement of 
2.2 g/L sodium bicarbonate (Sigma-Aldrich, MO), 11.5 ml/L penicillin/streptomycin 
Solution (Lonza, MD), 4.1 ml/L amphotericine B (Mediatech, VA), and 113 ml/L 
fetal bovine serum (Mediatech, VA). After reaching a confluence of 80%, depending 
on the experiments: 1) cells were treated with 0-50 μM cadmium chloride, 0-50 μM 
ethacrynic acid (EA) (Sigma-Aldrich, MO), or 0-100 μM buthionine sulfoximine 
(BSO) (Sigma-Aldrich, MO) for 5 hours; 2) cells were pretreated with 0-10 mM 
glutathione (GSH) (Sigma-Aldrich, MO) or 0-10 mM N-acetyl-cysteine (NAC) 
(Sigma-Aldrich, MO) for 2 hours, then with or without GSH or NAC staying in the 
media, cells were treated with 0-50 μM cadmium chloride, 0-50 μM ethacrynic acid 
(EA) (Sigma-Aldrich, MO), or 0-100 μM buthionine sulfoximine (BSO) 
(Sigma-Aldrich, MO) for 5 hours; 3) cells were pretreated with 0-4 mM apocynin, 
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0-20 μM diphenyleneiodonium (DPI) (Sigma-Aldrich, MO), or 0-20 mM tiron 
(Sigma-Aldrich, MO) for 2 hours, followed with the exposure to 0-50 μM cadmium 
for 5 hours. 
3. Determination of HO-1 mRNA expression 
The cells were harvested and centrifuged in 500 rpm for 5 minutes. Total RNA 
was isolated from the cells by using a Qiagen RNeasy Mini kit (Qiagen, CA). The 
HO-1 mRNA expression was determined by reverse transcription polymerase chain 
reaction (RT-PCR) analysis using a Qiagen OneStep RT-PCR kit (Qiagen, CA) and 
HO-1 primers (Qiagen, CA). The HO-1 PCR upper and lower primer sequences were: 
5’-TGTGGCAGCTGTCTCAAACCTCCA-3’ and 
5’-TTGAGGCTGAGCCAGGAACAGAGT-3’. The β-actin QuantumRNA 
primer/competimer sets (Ambion, TX) were used as internal standard. The RT-PCR 
conditions were 30 minutes at 50 °C, followed by 15 minutes at 95 °C (RT), then 0.5 
minutes at 95 °C, 0.5 minutes at 60 °C, and 1 minute at 72 °C (PCR) for 25 cycles. 
The resulting cDNA products were separated by electrophoresis in 2% agarose gel 
with ethidium bromide staining. For the target gene (HO-1), the PCR product size was 
175 base pairs (bp). For the internal control, β-actin, the PCR product size was 294 
bp. 
4. Western immunoblotting analysis of HO-1 protein 
The cells were harvested, washed and centrifuged in 500 rpm for 5 minutes in 
phosphate buffered saline (PBS). The cells then lysed using radioimmunoprecipitation 
assay (RIPA) buffer (PBS, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% 
sodium dodecyl sulfate, and Roche Complete Protease Inhibitor Cocktail, pH 7.4) and 
sit on ice for 30 minutes. Then, the cell lysate was centrifuged at 15,000 rpm for 20 
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minutes at 4 °C, and the supernatant was saved. The protein concentration of the 
supernatant was measured using a BCA protein assay kit (Pierce, IL). Then cell lysate 
supernatant (100 μg protein) was electrophoresed using Novex NuPAGE (Invitrogen, 
CA) mini-gels (4-12% Bis-Tris) in NuPAGE MOPS SDS Running Buffer (Invitrogen, 
CA), followed by blotting the gel to nitrocellulose membrane. Blotting was performed 
for 1 hour at 25 °C in NuPAGE Transfer Buffer (Invitrogen, CA). The membrane was 
incubated overnight at 4 °C with HO-1 goat monoclonal antibody (Santa Cruz, CA) in 
blocking buffer consisting 5% skim milk powder in TBST (20 mM Tris-HCl, 150 
mM sodium chloride, 0.05% Tween 20, pH 7.4) (1:1,000). After being washed three 
times with TBST for 30 minutes, the membrane was incubated for 2 hours at 25 °C 
with rabbit anti-goat IgG/HRP conjugate (Santa Cruz, CA) in blocking buffer 
(1:100,000). Finally, after being washed again, the membrane was placed in a plastic 
pouch for incubation with Thermo Scientific Super Signal West Femto 
Luminol/Enhancer Solution (Thermo Scientific, IL) for 5 minutes before analysis 
(Kodak digital scienceTM image station 440 CF). Then the membrane was washed 
with Restore Western Blot Stripping Buffer (Thermo Scientific, IL) and incubated 
with mouse monoclonal anti-β-actin antibody in blocking buffer (1:40,000) for 2 
hours at 25 °C. After being washed three times with TBST for 30 minutes, the 
membrane was incubated with HRP-conjugated goat polyclonal anti-mouse IgG 
(Santa Cruz, CA) in blocking buffer (1:200,000) for 1 hour at 25 °C. Then, the 
membrane was washed in TBST and processed for analysis as before. 
5. Determination of HO-1 enzyme activity 
The cells were harvested, washed and centrifuged in 500 rpm for 5 minutes in 
4 °C PBS. Cell pellets were resuspended in 100 mM phosphate buffer containing 2 
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mM magnesium chloride (MgCl2), and were sonicated. After being spinned at 15,000 
rpm for 10 minutes at 4 °C, the supernatant was saved and protein in the supernatant 
was determinated. Then 0.8 mg protein was used to quantitate HO-1 enzyme activity 
in a reaction volume of 1 ml, containing 0.1 ml liver cytosol, 1 mM NADPH, 0.25 
mM hemin, 2 mM glucose-6-phosphate, and 0.002 U/μL glucose-6-phosphate 
dehydrogenase. The reaction was performed at 37 °C for 1 hour in the dark and 
stopped by adding 1 ml of chloroform. The tubes were vortexed thoroughly followed 
by centrifugation at 500 rpm for 5 minutes. Finally the chloroform layers were 
scanned on a spectrophotometer at 464 nm with the background at 530 nm. The HO-1 
enzyme activity was expressed as formation of pmol bilirubin per hour per milligram 
of protein.  
6. Intracellular glutathione determination by using Ellman’s reagent 
Cells were harvested, washed with cold PBS, and centrifuged in 3,000 rpm for 3 
minutes at 4 °C. Cell pellets were resuspended with lyse buffer containing 50 mM tris 
and 1 mM EDTA (pH 6.8), and were sonicated, followed by being spun at 15,000 rpm 
for 10 minutes at 4 °C. Supernatant was diluted to the concentration of 125 μg 
protein/100 μl, and 10 μl of 30% trichloroacetic acid (TCA) was added to 300 μl 
supernatant. After sitting on ice for 15 minutes, the homogenate was centrifuged at 
3,000 rpm for 10 minutes at 4 °C. Finally, the absorbance of the visible light at 412 
nm of the homogenate containing 100 μl supernatant, 880 μl of TE buffer containing 
0.25 M tris, 20 mM EDTA (pH 8.2), and 20 μl of 10 mM 5,5'-dithiobis- 
(2-nitrobenzoic acid) (DTNB) was measured by using a spectrophotometer.  
7. Intracellular glutathione determination by using fluorescence microscopy 
Cells were washed with Hank’s buffered saline solution (HBSS), and incubated 
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with 20 μM monochlorobimane (Invitrogen, CA) for 30 minutes at room temperature. 
Then the cells were washed with HBSS again, and were examined by using 
fluorescence microscope (UV filter).  
8. Nuclear extraction preparation 
Nuclear extracts were prepared by using Active Motif Nuclear Extract Kit 
(Active motif, CA). Cells were washed with and harvested in 10 ml ice-cold 
phosphate buffered saline/phosphatase inhibitor buffer (PBS/PIB), followed by 
spinning at 300 rpm for 5 minutes at 4 °C. The cell pellets were resuspended with 1 
ml ice-cold hypotonic buffer (HB) buffer and sit on ice in 1.5 ml tubes for 15 minutes. 
After adding 50 μl 10% Nonidet P-40, the tubes were vortexed vigorously for 10 
seconds, followed by spinning for 30 seconds at 4 °C. The nuclear pellets were 
resuspended in 50 μl complete lyse buffer and agitated on ice for 30 minutes on an 
agitating platform. The homogenate was centrifuged for 10 minutes at 14,000 rpm at 
4°C and the supernatant was saved. 
9. Western immunoblotting analysis of nuclear Nrf-2 
Nuclear extract (60 μg protein) was electrophoresed using Novex NuPAGE 
(Invitrogen, CA) mini-gels (4-12% Bis-Tris) in NuPAGE MOPS SDS Running Buffer 
(Invitrogen, CA), followed by blotting the gel to nitrocellulose membrane. Blotting 
was performed for 1 hour at 25 °C in NuPAGE Transfer Buffer (Invitrogen, CA). The 
membrane was incubated overnight at 4 °C with Nrf-2 rabbit polyclonal antibody 
(1:1,000) (Santa Cruz, CA) in blocking buffer consisting 5% skim milk powder in 
TBST (20 mM Tris-HCl, 150 mM sodium chloride, 0.05% Tween 20, pH 7.4). After 
being washed three times with TBST for 30 minutes, the membrane was incubated for 
2 hours at 25 °C with goat anti-rabbit IgG/HRP conjugate (Santa Cruz, CA) in 
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blocking buffer (1:20,000). Finally, after being washed again, the membrane was 
placed in a plastic pouch for incubation with Thermo Scientific Super Signal West 
Femto Luminol/Enhancer Solution (Thermo Scientific, IL) for 5 minutes before 
analysis (Kodak digital scienceTM image station 440 CF). Then the membrane was 
washed with Restore Western Blot Stripping Buffer (Thermo Scientific, IL) and 
incubated with goat polyclonal anti-lamin B antibody in blocking buffer (1:1,000) for 
2 hours at 25 °C. After being washed three times with TBST for 30 minutes, the 
membrane was incubated with HRP-conjugated rabbit anti-goat IgG (Santa Cruz, CA) 
in blocking buffer (1:200,000) for 1 hour at 25 °C. Then, the membrane was washed 
in TBST and processed for analysis as before. 
10. Determination of nuclear expression of Nrf-2 by using TransAMTM Nrf-2 kit 
Nuclear Nrf-2 expression was determined by using TransAMTM Nrf-2 kit (Active 
Motif, CA). 10 μl (60 μg protein) nuclear extracts were added to wells of TransAMTM 
plate immobilized with antioxidant responsive element (ARE)-containing 
oligonucleotide with 40 μl complete binding buffer, and were incubated for 1 hour at 
room temperature with mild agitation. The wells then were washed 3 times with 200 
μl wash buffer, followed by the addition of 100 μl Nrf-2 primary antibody (1:1,000 
diluted in antibody binding buffer). After incubating for 1 hour at room temperature 
and washed 3 times with 200 μl wash buffer, 100 μl horseradish peroxidase 
(HRP)-conjugated second antibody (1:1,000 diluted in antibody binding buffer) was 
added and incubated for 1 hour at room temperature. After washing 4 times with 200 
μl wash buffer, 100 μl developing solution (room temperature) was added and 
incubated for 2-15 minutes until a dark blue color developed. Then, 100 μl stop 
solution was added and the absorbance of a visible light at 450 nm with a reference 
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wavelength of 655 nm was measured using a spectrophotometer. 
11. Determination of nuclear expression of Nrf-2 by using immunocytofluorescence 
microscopy   
Cells were grown in LabTek chamber slides, and were fixed with formaldehyde 
(4% in PBS) at room temperature for 15 minutes. After being incubated with Triton 
X-100 (0.2% in PBS) for 5 minutes at 4 °C, the slides were blocked with bovine 
serum albumn (1% in PBS) for 3 hours at room temperature. Then rabbit Nrf-2 
polyclonal antibody (1:500) was added and incubated overnight at 4 °C. After 
washing 3 times for 30 minutes, goat anti-rabbit IgG conjugated with Alexa Fluor 488 
(Molecular Porbes Inc., Eugene OR) (1:1,000) was added and incubated for 2 hours at 
room temperature. After washing, the slides were examined under FITC filter and UV 
filter (4’,6-diamidino-2-phenylindole (DAPI) was used as a counterstain to visualize 
nuclei).  
12. Examination of NAPDH:cytochrome P450 reductase (NCPR) activity 
The cells were harvested, washed, centrifuged in 500 rpm for 5 minutes at 4 °C 
PBS. Cell pellets were resuspended in 100 mM phosphate buffer containing 0.3 M 
potassium (pH 7.6) and were sonicated. After spinning at 15,000 rpm for 10 minutes 
at 4 °C, the supernatant was saved. Then, supernatant (50 μg), NADPH (final 
concentration, 50 μM) and cytochrome c (final concentration, 50 μM) were added to 
reductase assay buffer containing 50 mM potassium phosphate, 0.1 mM tetrasodium 
dihydrate, and 0.3 M potassium chloride (pH 7.4) (final volume, 1 ml). The initial rate 
of cytochrome c reduction was monitored for 10 minutes by using the absorbance at 
550 nm (using an extinction coefficient of 21 mM-1 cm-1). NCPR enzyme activity was 
expressed as μmol per minute per mg protein. 
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13. Statistical analysis 
HO-1/β-actin mRNA ratio, HO enzyme activity, glutathione concentration, 
nuclear Nrf-2 expression, and NCPR enzyme activity data were analyzed via 
two-tailed unpaired t test using SPSS 16.0 for Microsoft Windows XP (SPSS Inc., 
IL).  
Results 
1. Cadmium, EA, and BSO decreased intracellular glutathione 
To investigate the effect of cadmium on the intracellular glutathione, experiments 
were conducted to compare the effects of cadmium and two glutathione inhibitors, EA 
and BSO on intracellular glutathione levels. Cells were treated with 0-50 μM 
cadmium chloride, 0-50 μM EA, or 0-100 μM BSO for 5 hours. The intracellular 
glutathione concentration was first determined by using Ellman’s reagent, 
5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB). DTNB may react with thiol groups in 
GSH, and release TNB- to form TNB2- which has a yellow color and could be 
quantified in a spectrophotometer by measuring the absorbance of visible light at 412 
nm. It was found that cadmium, EA, and BSO decreased the light absorbance, 
indicating decreased intracellular GSH levels caused by cadmium, EA, and BSO 
(Figure III-1, page 80). Then the result was confirmed by using monochlorobimane. 
When incubated with the cells, monochlorobimane enters the cells and is quickly 
converted to a fluorescent GSH conjugate (GS-monochlorobimane) which appears a 
blue color in a fluorescence microscope (UV filter). It was found that, after being 
incubated with monochlorobimane, the cells treated with cadmium, EA, or BSO, had 
less densities of blue color than the control cells, indicating decreased intracellular 
GSH levels caused by cadmium, EA, and BSO (Figure III-2, page 81). 
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2. The effects of Cadmium, EA, and BSO, on HO-1 mRNA expression 
Then, experiments were conducted to compare the effects of cadmium, EA, and 
BSO on the expression of HO-1. Cells were pretreated with 0-10 mM GSH or 0-10 
mM NAC for 2 hours, then with or without GSH or NAC remaining in the media, 
cells were exposed to 0-50 μM cadmium chloride, 0-50 μM EA, or 0-100 μM BSO 
for 5 hours. It was found that cadmium upregulated HO-1 mRNA expression. 
However, in the cells treated with GSH and NAC, which were left in the cell culture 
media until the five-hour cadmium treatment finished, the upregulating effect of 
cadmium on HO-1 mRNA expression was decreased (Figure III-3 A, page 82). But in 
the cells treated with GSH and NAC which were removed from cell culture media 
before cadmium treatment, the upregulating effect of cadmium on HO-1 mRNA 
expression was not affected (Figure III-3 B, page 82). Similar effects were observed 
in the cells treated with EA. The treatment with EA upregulated HO-1 mRNA 
expression. However, in the cells treated with GSH and NAC which were remained in 
the cell culture media until five-hour EA treatment finished, the upregulating effect of 
EA on HO-1 mRNA expression was decreased (Figure III-3 C, lane 6 and 8, page 82). 
But in the cells treated with GSH and NAC, which were removed from cell culture 
media before EA treatment, the upregulating effect of EA on HO-1 mRNA expression 
was not affected (Figure III-3 C, lane 5 and 7, page 82). Interestingly, the treatment of 
BSO has not influence on HO-1 mRNA expression (data is not shown).  
3. Cadmium and EA, but not BSO, increased the nuclear expression of Nrf-2 
The oxidative stress-responding transcription factor nuclear factor erythroid-2 
related factor 2 (Nrf-2) has been thought to play a critical role in xenobiotic-induced 
HO-1 upregulation. Therefore, experiments were conducted to compare the effects of 
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cadmium, EA, and BSO on nuclear Nrf-2 expression. Cells were treated with 0-50 
μM cadmium chloride, 0-50 μM EA, or 0-100 μM BSO for 5 hours. By using Western 
immunoblotting analysis, it was found that cadmium and EA, but not BSO, 
upregulated nuclear Nrf-2 protein expression (Figure III-4 B, page 84). The result was 
confirmed by using TransAMTM Nrf-2 kit and Fluorescence Microscopic Analysis. 
When Nrf-2 containing nuclear extract added to the wells of TransAMTM plate coated 
with antioxidant responsive element (ARE)-containing oligonucleotide, Nrf-2 binds to 
ARE. Then after being incubated with a primary Nrf-2 antibody and a horseradish 
peroxidase (HRP)-conjugated second antibody, a dark blue color could be developed 
which could be quantified by measuring the absorbance of a visible light at 450 nm 
with a reference wave length of 655 nm using spectrophotometer. Similar to the 
results of Western immunoblotting analysis, the nuclear extract of the cells treated 
with cadmium and EA had a significantly higher light absorbance than the nuclear 
extract of control cells and cells treated with BSO, indicating cadmium and EA, but 
not BSO, upregulated nuclear Nrf-2 protein expression (Figure III-4 A, page 84). 
Finally, cells were grown in LabTek chamber slides and were fixed with 
formaldehyde. After being incubated with Triton X-100, the slides were incubated 
with a Nrf-2 primary antibody and a second antibody conjugated with Alexa Fluor 
488 which appears as green color under a FITC filter. Then, the slides were incubated 
with 4’,6-diamidino-2-phenylindole (DAPI) which binds strongly to DNA and 
appears as blue color under a UV filter. By examining under fluorescence microscope, 
it was found that the cells treated with cadmium and EA had higher densities of green 
color than the control cells and cells treated with BSO under a FITC filter. The nuclei 
of the cells, which had been bound to DAPI, were visualized with a blue color under a 
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UV filter. The images with green color under the FITC filter and images with blue 
color under the UV filter could be overlapped (Figure III-5, page 86). These 
observations suggest that cells treated with cadmium and EA had higher nuclear Nrf-2 
expression than control cells and cells treated with BSO.  
4. HCT116 cells expressed NOX-1 protein and NOX inhibitors, apocynin and DPI, 
and superoxide scavenger, tiron, decreased the upregulating effects of cadmium on 
HO-1 protein and mRNA expression 
To investigate whether HCT116 cells express NOX, and the role of 
NOX-produced ROS in HO-1 protein and mRNA expression, experiments were 
conducted to see if NOX-1 is expressed in the cells and the influence of NOX 
inhibitors, apocynin and DPI, and superoxide scavenger, tiron, on the upregulating 
effects of cadmium on HO-1 mRNA and protein expression. It was found that NOX-1 
protein was constitutively expressed in HCT116 cells, and this expression was not 
influenced by the treatment with DFO (Figure III-6 A, page 88). The treatment with 
cadmium increased HO-1 mRNA expression; however, the inhibition of NOX and 
superoxide decreased the upregulating effect of cadmium on HO-1 mRNA (Figure 
III-6 C, page 88); the ratio of HO-1 mRNA/β-actin mRNA in the cells treated 
cadmium was increased dramatically compared to the control cells; however, the 
ratios of HO-1 mRNA/β-actin mRNA in the cells treated with apocynin, DPI, and 
tiron were significantly decreased compared to the cells treated with cadmium 
(p<0.05) (Figure III-6 B, page 88). Similarly, the treatment with cadmium increased 
HO-1 protein expression, and the inhibition of NOX and superoxide decreased the 
upregulating effect of cadmium on HO-1 protein expression (Figure III-6 D, page 88). 
5. NADPH oxidase inhibitors, apocynin and DPI, and superoxide scavenger, tiron, 
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decreased the upregulating effect of cadmium on HO-1 enzyme activity 
Then experiments were conducted to investigate the effects of NOX inhibitors, 
apocynin and DPI, and superoxide scavenger, tiron, on the upregulating effect of 
cadmium on HO-1 enzyme activity. It was found that the inhibition of NOX and 
superoxide decreased the upregulating effect of cadmium on HO-1 enzyme activity 
(p<0.05) (Figure III-7, page 90).  
6. DPI, but not apocynin and tiron, inhibited NADPH:cytochrome P450 reductase 
(NCPR) enzyme activity 
Finally, experiments were conducted to investigate the influences of DPI, 
apocynin, and tiron on NCPR activity. It was found that DPI (Figure III-8 A, page 92), 
but not apocynin and tiron (Figure III-8 B, page 92), decreased NCPR enzyme 
activity. 
Discussion 
It was observed in the previous study that iron plays a critical role in 
cadmium-induced HO-1 upregulation, but no mechanism was identified. In the 
present study, experiments were conducted to help explain the effects of cadmium on 
HO-1 gene expression in HCT116 cells with or without iron deficiency.  
Although the mechanisms of the influences of cadmium on gene expression are 
not fully understood, some cellular effects of cadmium have been demonstrated. 
Studies have shown that cadmium may influence gene expression by increasing 
intracellular accumulation of ROS via interaction with mitochondrion, antioxidant 
enzymes including catalase and superoxide dismutase (SOD), and intracellular 
glutathione (Patrick 2003). 
Glutathione (GSH) is the major and the most abundant intracellular antioxidant. 
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Studies have shown that intracellular GSH concentrations could be reduced 
dramatically in response to oxidative stress (Ariigo 1999). Furthermore, the 
GSH/GSSG ratio has been used to indicate the intracellular redox state. The decrease 
of intracellular GSH concentration may result in a decrease of GSH/GSSG ratio, 
indicating an abnormal intracellular redox state, therefore, influences the expression 
of variety of redox-sensitive genes by modulating the redox-sensitive transcription 
factors such as NF-κB, AP-1, and Nrf-2.  
Studies have shown that the thiol groups have the ability to bind to metals (Giles 
2003). Therefore, the effect of cadmium on intracellular GSH was investigated by 
comparing with two GSH inhibitors, EA and BSO. Studies have shown that EA and 
BSO inhibit intracellular GSH trough different mechanisms. EA depletes GSH 
through conjugating to GSH via glutathione-S-transferases (Shen 1995), but BSO 
inhibits GSH synthesis (Griffith 1979). This means that EA may have a more 
immediate and direct effect on the depletion of intracellular glutathione. 
In the present study, it was observed that cadmium decreased intracellular 
glutathione level. This result was similar to the effects of EA and BSO on intracellular 
glutathione levels (Figure III-1 and 2, page 80-81). It was also observed that cadmium 
and EA, but not BSO, increased HO-1 mRNA (Figure III-3, page 82) and nuclear 
Nrf-2 protein expression (Figure III-4 and 5, page 84-86). Therefore, it is very likely 
that similar to EA, cadmium decreases intracellular GSH level by directly conjugating 
to GSH.  
To test this speculation, another experiment was conducted. The cells were 
treated with GSH or NAC. Then, with or without GSH and NAC left in the cell 
culture media, the cells were exposed to cadmium or EA. It was found that adding 
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GSH and NAC into the cell culture media decreased the upregulating effects of 
cadmium and EA on HO-1 mRNA expression, suggesting cadmium has similar 
conjugating effects on GSH and NAC as EA does. The decreased intracellular GSH 
level caused by cadmium may result in the intracellular accumulation of ROS which 
activates transcription factors of HO-1, therefore inducing HO-1 expression. This 
result is consistent with other researchers’ work (Lopez 2006, Figuereido-Pereira 
1998, Taketani 1989). Both in Lopez and Figuereido-Pereira studies reported a 
decreased intracellular GSH level in neurons after exposing to cadmium. Furthermore, 
Taketani group observed that cadmium have the property to upregulate HO-1 gene 
expression.  
Several transcription factors, including heat-shock factor (HSF), nuclear 
factor-κB (NF-κB), activator protein-1 (AP-1), and nuclear transcription factor 
NF-E2-related factor-2 (Nrf-2), have been shown to be related to the regulation of the 
expression of HO-1. Among them, Nrf-2 was thought to be particular important and 
related the upregulation of HO-1 by a variety of xenobiotics (Otterbin 2002, Alam 
1999). In normal conditions, Nrf-2 is sequestered in the cytoplasm as an inactive form 
by Keap1. Keap1 binds to Nrf-2, preventing Nrf-2 translocation into the nucleus and 
increasing the degradation of Nrf-2 by ubiquitin-proteasome pathway, therefore 
preventing HO-1 upregulation activated by Nrf-2 (Steward 2003). Keap1 is a protein 
rich in cysteine residues which makes it to be sensitive to xenobiotics and oxidative 
stress (Itoh 1999 and 2003, McMahon 2003). With the appearance of ROS, Nrf-2 is 
dissociated from Keap1 and is translocated into the nucleus where it binds to HO-1 
enhancers, including the stress responsive element (StRE) (Inamdar 1996) or Maf 
recognition element (MARE) (Kataoka 1994). Studies have shown that MARE/StRE, 
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small Maf proteins, Nrf-2, and Bach1 were involved in the regulation of HO-1 gene 
expression. The small Maf proteins form heterodimers with Nrf-2 to activate (Ishii 
2000, Kataoka 2001), or with Bach1 to repress MARE-dependent HO-1 gene 
expression (Igarashi 1998). It has been reported that cadmium upregulates HO-1 
expression by increasing the export of Bach1 from nucleus (Suzuki 2003) and by 
stabilizing Nrf-2 through a mechanism of decreasing the degradation of Nrf-2 by the 
ubiquitin-proteasome pathway (Steward 2003). In the present study, it was observed 
that cadmium upregulated HO-1 expression by increasing nuclear Nrf-2 protein 
expression (Figure III-4 and 5, page 84-86). Putting the results together, it is possible 
that cadmium may increase intracellular accumulation of ROS by depleting 
intracellular GSH. The accumulation of ROS then may cause the dissociation of Nrf-2 
from Keap1 which decreases the degradation of Nrf-2 by ubiquitin-proteasome 
pathway and increases translocation of Nrf-2 from cytosol into nucleus. The increased 
nuclear Nrf-2 then activates HO-1 gene expression. 
Studies have demonstrated that ROS could be produced in several potential 
sources including mitochondrion, NOX, cytochrome P450, and other enzymes. 
Among them, NOX and mitochondrion are believed to be two major sources of ROS. 
In the previous study, it was observed that DFO and DPD decreased the upregulating 
effect of cadmium on HO-1 gene expression, and these modulations of DFO or DPD 
appeared to be at the pre-transcriptional level. So, it is possible that DFO and DPD 
decreased the upregulating effect of cadmium on HO-1 by interrupting the production 
of ROS in the two major sources, mitochondrion or NOX. Since NOX contains two 
hemes anticipating the electron transport in the enzyme (Finegold 1996), it was 
speculated that DFO and DPD decrease the upregulating effect of cadmium on HO-1 
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by depleting the iron in the hemes, the components of NOX, hence affect the electron 
transport and reduce NOX-produced ROS. Therefore, in the condition of cadmium 
exposure in iron-deficient cells, no intracellular accumulation of ROS occurs because 
of possible impaired NOX function, even though the intracellular glutathione level is 
decreased by cadmium. This speculation was supported by the following observation: 
NOX inhibitors, apocynin and DPI, and superoxide scavenger, tiron, decreased the 
upregulating effects of cadmium on HO-1 mRNA, protein expression (Figure III-6, 
page 88) and enzyme activity (Figure III-7, page 90). Despite the fact that DPI 
(0.05-20 μM) had a much more potent inhibiting effect on HO-1 activity than 
apocynin (0.5-4 mM) and tiron (5-20 mM), these effects were very similar to the 
effects of DFO and DPD on HO-1 mRNA and protein expression and enzyme activity, 
suggesting the important role of NOX-induced ROS in the cadmium-induced 
upregulation of HO-1.  
The degradation of heme begins with the formation of ferrous iron from ferric 
iron in heme-HO-1 complex which needs an electron donated from 
NADPH:cytochrome P450 reductase (NCPR) (Yoshida 1978). This means that HO-1 
activity could be influenced by the activity of NCPR. Since both NOX-1 and NCPR 
are flavoprotein, and DPI is a flavoprotein inhibitor (Chakraborty 2002), so it was 
speculated that when the cells were treated with DPI, both NOX-1 and NCPR could 
be inhibited by DPI; but when the cells were treated with apocynin or tiron, only the 
intracellular ROS level, but not NCPR enzyme activity, was decreased. To test this 
hypothesis, NCPR enzyme activities of the cells with the treatments with DPI, 
apocynin, and tiron were determined. It was found that DPI inhibited NCPR enzyme 
activity from a very low concentration (0.05-5 μM) (Figure III-8 A, page 92), but no 
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inhibiting effect of apocynin or tiron on NCPR enzyme activity was observed (Figure 
III-8 B, page 92). The results may explain that why DPI was so potent on the 
inhibition of NCPR enzyme activity compared to apocynin and tiron, and on the other 
hand, support the notion that the function of HO-1 requires the participation of NCPR. 
In conclusion, as depicted in Figure III-9 (page 93), the results of the present 
study suggest that NOX-induced ROS plays an important role on the 
cadmium-induced upregulation of HO-1. Cadmium depletes the intracellular 
glutathione which may result in the intracellular accumulation ROS. It is likely that 
upon the presence of ROS, Nrf-2 may be dissociated from Keap1. The dissociation of 
Nrf-2 from keap1, therefore, decreases the degradation of Nrf-2 via 
ubiquitin-proteasome pathway and increases the translocation of Nrf-2 from cytosol 
into nucleus where Nrf-2 activates the expression of HO-1. Iron chelators, DFO and 
DPD, deplete iron in the hemes, the components of NOX, interrupting the production 
of ROS from NOX, therefore decrease the upregulating effects of cadmium on HO-1. 
The results also support the notion that the function of HO-1 requires the anticipation 
of NCPR. 
In closing, my thesis suggests that as a contaminant and carcinogen, cadmium 
causes cellular damages via depleting intracellular GSH, therefore increase 
intracellular accumulation of NOX-produced ROS. As a defending mechanism for 
cytoprotection against cadmium, HO-1 mRNA and protein and enzyme activity in the 
cells are upregulated, but this upregulation could be weakened in iron-deficient cells 
caused by DFO and DPD, which implies that iron-deficient population could be more 
likely to develop adverse health problems than iron-sufficient population in the 
condition of cadmium exposure. However, there are still lots of research questions 
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should be answered some of which are stated in the epilogue.  
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Figure III-1. Cadmium, EA, and BSO decreased the intracellular glutathione 
levels (determined by using Ellman’s reagent). Cells were treated with 0-50 μM 
cadmium chloride, 0-50 μM EA, or 0-100 μM BSO for 5 hours. The intracellular 
glutathione concentration was determined using Ellman’s reagent, 
5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB). DTNB may react with thiol groups in 
GSH, and release TNB- to form TNB2- which has a yellow color and could be 
quantified in a spectrophotometer by measuring the absorbance of a visible light at 
412 nm. Cadmium, EA, and BSO decreased the light absorbance, indicating 
decreased intracellular GSH levels caused by cadmium, EA, and BSO. The values 
given are means ± S.E.M. from three independent experiments (*, the treatments with 
EA or BSO vs. control, p<0.05). 
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Figure III-2. Cadmium, EA, and BSO decreased the intracellular glutathione 
levels (determined by using monochlorobimane). Cells were treated with 0-50 μM 
cadmium chloride, 0-50 μM EA, or 0-100 μM BSO for 5 hours. The intracellular 
glutathione concentration was determined by using monochlorobimane. By incubation 
with the cells, monochlorobimane enter the cells and is quickly converted to a 
fluorescent GSH conjugate (GS-monochlorobimane) which appears a blue color 
under fluorescence microscope (UV filter). After being incubated with 
monochlorobimane, the cells treated with cadmium, EA, or BSO, have less density of 
blue color than the control cells, indicating decreased intracellular GSH levels caused 
by cadmium, EA, and BSO. The images given represent three independent 
experiments.  
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Figure III-3. The effects of cadmium and EA on HO-1 mRNA expression. Cells 
were pretreated with 0-10 mM GSH or 0-10 mM NAC for 2 hours, then with or 
without GSH or NAC remaining in the cell culture media, cells were exposed to 0-50 
μM cadmium chloride or 0-50 μM EA 5 hours. A: cadmium upregulated HO-1 
mRNA expression. In the cells treated with GSH and NAC which were left in the cell 
culture media until five-hour cadmium treatment finished, the upregulating effect of 
cadmium on HO-1 mRNA expression was decreased. B: in the cells treated with GSH 
and NAC which were removed from cell culture media before cadmium treatment, the 
upregulating effect of cadmium on HO-1 mRNA expression was not affected. C: 
similar effects of the treatment with EA were observed. EA upregulated HO-1 mRNA 
expression. In the cells treated with GSH and NAC which were left in the cell culture 
media until five-hour EA treatment finished, the upregulating effect of EA on HO-1 
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mRNA expression was decreased (lane 6 and 8); in the cells treated with GSH and 
NAC which were removed from cell culture media before EA treatment, the 
upregulating effect of EA on HO-1 mRNA expression was not affected (lane 5 and 7). 
The images given represent three independent experiments. 
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Figure III-4. Cadmium and EA, but not BSO, increased nuclear Nrf-2 expression 
(by using Western immunoblotting analysis and TransAMTM kit). Cells were treated 
with 0-50 μM cadmium chloride, 0-50 μM EA, or 0-100 μM BSO for 5 hours. B: 
Western immunoblotting analysis indicated that cadmium and EA, but not BSO, 
upregulated nuclear Nrf-2 expression. A: when Nrf-2 containing nuclear extract added 
to the wells of TransAMTM plate which are coated with antioxidant responsive 
element (ARE)-containing oligonucleotide, Nrf-2 binds to ARE. After being 
incubated with a primary Nrf-2 antibody and a horseradish peroxidase 
(HRP)-conjugated second antibody, a dark blue color could be developed which could 
be quantified by measuring the absorbance of a visible light at 450 nm with a 
reference wave length of 655 nm using spectrophotometer. Similar to the result of 
Western immunoblotting, the nuclear extract of the cells treated with cadmium and 
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EA had a significantly higher light absorbance than the nuclear extract of control cells 
and cells treated with BSO, indicating cadmium and EA, but not BSO, upregulated 
nuclear Nrf-2 protein expression. The values given are means ± S.E.M. from three 
independent experiments (*, the treatments with cadmium or EA vs. control, p<0.05). 
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Figure III-5. Cadmium and EA, but not BSO, increased nuclear Nrf-2 expression 
(by using immunocytofluorescence microscopy). Cells were grown in LabTek 
chamber slides and were fixed with formaldehyde. After being incubated with Triton 
X-100, the slides were incubated with Nrf-2 primary antibody and second antibody 
conjugated with Alexa Fluor 488 which appears a green color under a FITC filter. 
Then the slides were incubated with 4’,6-diamidino-2-phenylindole (DAPI) which 
binds strongly to DNA and appears a blue color under an UV filter. Cells treated with 
cadmium and EA has a higher density of green color than the control cells and cells 
treated with BSO under a FITC filter. The nuclei of the cells, which have been bound 
to DAPI, were visualized with a blue color under an UV filter. The images with green 
color under the FITC filter and images with blue color under the UV filter could be 
overlapped indicating nuclear Nrf-2 expression. These observations indicate that a 
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higher nuclear Nrf-2 protein expression in cells treated with cadmium and EA than in 
control cells and cells treated with BSO. The images give represent three independent 
experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
88
Apocynin (mM):   0     0     2    4    0     0    0     0
Tiron (mM):   0     0     0    0   10   20   0     0
DPI (μM):   0     0     0    0     0    0   10   20
Cadmium (μM):   0    50   50   50  50  50  50   50
Apocynin (mM):   0     0     2    4    0     0    0     0
DPI (μM):   0     0     0    0   0    0  10   20
Tiron (mM):   0     0     0    0   10   20   0     0
Cadmium (μM):   0    50   50   50 50  50 50 50
*
NOX-1
HO-1
β-actin
HO-1
β-actin
β-actin
DFO:   0     100  μM 
H
O
-1
: β
-a
ct
in
 
ra
tio
A B
D
C
 
Figure III-6. HCT116 cells expressed NOX-1 protein and NOX inhibitors, 
apocynin and DPI, and superoxide scavenger, tiron, decreased the upregulating effects 
of cadmium on HO-1 protein and mRNA expression. Firstly, cells were treated with 
or without 0-100 μM DFO for 24 hours. Then, cells were pretreated with 0-4 mM 
apocynin, 0-20 μM DPI, or 0-20 mM tiron for 2 hours, followed with the exposure to 
0-50 μM cadmiumn for 5 hours. A: NOX-1 protein was constitutively expressed in 
HCT116 cells, and this expression was not influenced by the treatment with DFO. C: 
the treatment with 50 μM cadmium increased HO-1 mRNA expression; however, the 
pretreatments with 4 mM apocynin, 20 μM DPI, or 20 mM tiron decreased the 
upregulating effect of cadmium on HO-1 mRNA. B: the ratio of HO-1 mRNA/β-actin 
mRNA in the cells treated with 50 μM cadmium was dramatically increased compared 
to the control cells; however, the ratios of HO-1 mRNA/β-actin mRNA in the cells 
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treated with 4 mM apocynin, 20 μM DPI, or 20 mM tiron were significantly 
decreased compared to the cells treated with 50 μM cadmium (p<0.05). D: Similarly, 
the treatments with 50 μM cadmium increased HO-1 protein expression, and 
pretreatment with 4 mM apocynin, 20 μM DPI, or 20 mM tiron decreased the 
upregulating effect of cadmium on HO-1 protein expression. The values given are 
means ± S.E.M. from three independent experiments (*, the treatments with 4 mM 
apocynin, 20 mM tiron, or 20 μM DPI plus 50 μM cadmium vs. the treatment with 50 
μM cadmium, p<0.05). 
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Figure III-7. NADPH oxidase inhibitors, apocynin and DPI, and superoxide 
scavenger, tiron, decreased the upregulating effect of cadmium on HO-1 enzyme 
activity. Cells were pretreated with 0-4 mM apocynin, 0-5 μM DPI, or 0-20 mM tiron 
for 2 hours, followed with the exposure to 0-50 μM cadmium for 5 hours. A: the 
treatments with 1-4 mM apocynin significantly decreased the upregulating effect of 
cadmium on HO-1 enzyme activity. B: the treatments with 0.05-5 μM DPI 
significantly decreased the upregulating effect of cadmium on HO-1 enzyme activity. 
C: the treatments with 5-20 mM tiron significantly decreased the upregulating effect 
of cadmium on HO-1 enzyme activity decreased cadmium-induced upregulation of 
HO-1 enzyme activity. The values given are means ± S.E.M. from three independent 
experiments (*, the treatments with 1-4 mM apocynin, 5-20 mM tiron, or 0.05-5 μM 
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DPI plus 50 μM cadmium vs. the treatment with 50 μM cadmium, p<0.05).  
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Figure III-8. DPI, but not apocynin and tiron, inhibited NADPH: cytochrome 
P450 reductase (NCPR) enzyme activity. Cells were pretreated with 0-4 mM apocynin, 
0-5 μM DPI, or 0-20 mM tiron for 2 hours, followed with the exposure to 0-50 μM 
cadmium for 5 hours. A: compared to control cells and cells treated with cadmium, 
the treatment with 0.05-5 μM DPI significantly inhibited NADPH:cytochrome P450 
reductase (NCPR) enzyme activity (p<0.05). B: no inhibiting effect of apocynin and 
tiron on NCPR enzyme activity was observed. The values given are means ± S.E.M. 
from three independent experiments (*, the treatments with 0.05-5 μM DPI plus 50 
μM cadmium vs. the treatment with 50 μM cadmium, p<0.05).  
 
 
 
 
 
93
 
 
Figure III-9. Possible elucidation of the effects of cadmium on HO-1 in the cells 
with or without iron deficiency. NOX-induced ROS play an important role on the 
cadmium-induced upregulation of HO-1. Cadmium depletes the intracellular 
glutathione resulting in the intracellular accumulation ROS. It is likely that upon the 
intracellular accumulation of ROS, Nrf-2 may be released from Keap1 decreasing 
Nrf-2 degradation via ubiquitin-proteasome pathway and increasing the translocation 
of Nrf-2 from cytosol into nucleus where the expression of HO-1 is initiated. Iron 
chelators, DFO and DPD, deplete iron in the hemes, the components of NOX, 
interrupting the production of ROS from NOX, therefore decrease the upregulating 
effect of cadmium on HO-1. Furthermore, the function of HO-1 requires the 
participation of NCPR. 
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EPILOGUE 
In Chapter II and III, the results suggest that NOX-induced ROS play an important 
role in the cadmium-induced upregulation of HO-1. However, studies have shown that in 
addition to NOX, there are several other sources of intracellular ROS including 
mitochondrion. The mitochondrion has been shown to be another important and major 
source of ROS. But the role of mitochondrion-induced ROS on cadmium-upregulated 
HO-1 expression is not clear. Studies have shown that the respiratory chain in 
mitochondrion, where ROS are produced, contains iron-containing FeS clusters and 
cytochromes. So, if mitochondrion produced-ROS play a role on cadmium-induced HO-1 
upregulation, it is possible that these irons could also be depleted by DFO or DPD, 
resulting in decreased production of ROS and decreased upregulating effect of cadmium 
on HO-1. So future studies may be designed to investigate the effects of mitochondron-
induced ROS on cadmium upregulated HO-1 expression. To do that, the effects of 
mitochondrial inhititors, such as oligomycin, on the upregulating effect of cadmium on 
HO-1 could be investigated.  
The results in chapter III suggest that cadmium may induce cellular accumulation of 
ROS by depleting intracellular glutathione. With the increased ROS level, Nrf-2 could be 
released from Keap1 and be translocated into nucleus where it activates the expression of 
HO-1. Studies have shown that Keap1 is cysteine-rich protein which may be sensitive to 
oxidative stress, but my thesis studies did not demonstrate upstream pathways of the  
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activation of Nrf-2. Is there any protein kinase involved, such as protein kinase C (PKC)  
or MAPKs including extracellular signal-regulated protein kinase (ERK), c-Jun N-  
terminal kinase (JNK), and p38? To answer the question, the influences of the inhibitors 
of these protein kinases, such as H7 (for PKC), PD98059 (for ERK), AS601245 (for JNK) 
and SB202190 (for p38), on the upregulating effect of cadmium on HO-1 should be 
investigated in the future. 
Studies have shown cadmium may cause intracellular accumulation of ROS which 
results in lipid peroxidation of cell membrane and DNA damage, and the upregulation of 
HO-1 by cadmium has been believed as defending mechanism against cadmium toxicity. 
However, what kind protective role of HO-1 on cadmium toxicity is not clear. Does 
cadmium cause lipid peroxidation of cell membrane or DNA damage in HCT116 cells? If 
it does, what are the protective effects of HO-1 against these cadmium toxicities? To 
answer the questions, thiobarbituric acid reactive substances (TBARS) assay for lipid 
peroxidation and the single cell gel electrophoresis (SCGE or comet) assay for DNA 
damage could be conducted in the cells with or without HO-1 gene knock out.  
In my thesis, HCT116 colon cancer cell line was used. Studies have shown that 
cancer cells are different from normal cells in some aspects, one of which is that cancer 
cells may have different requirement and tolerance to ROS to maintain their cellular 
signaling and proliferation. In fact, it is unconclusive whether the upregulation of HO-1 is 
a beneficial mechanism for cancer cell proliferation or is a defending mechanism against 
cancer development. This means that it is not clear whether the results and conclusions 
obtained in my thesis could apply to normal cells, such as normal NCM460 (a normal 
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human colon mucosal epithelial cell line). So, similar studies should be conducted in 
normal cells to make a clear conclusion.  
Finally, my thesis investigated the influence of iron deficiency on the defending 
mechanism, HO-1 upregulation, against only one of xenobiotics, cadmium. So, future 
studies could be done to investigate the role of iron on the defending mechanism against 
other xenobiotics such drugs, especially highly toxic drug used in cancer therapeutic 
purpose.     
